Document:

Exhibit 4.1

 

 

 

 

UNDERWRITING AGREEMENT

TANZANIAN GOLD CORPORATION

6,695,652 Common Shares

 

December 16, 2019

 

R.F. Lafferty & Co., Inc.

40 Wall Street, 19th Floor

New York, NY 10005

 

Ladies and Gentlemen:

 

Tanzanian Gold Corporation, a company established under the Business Corporations Act (Alberta),
Canada (the “Company”), proposes, subject to the terms and conditions stated herein,
to sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are
acting as representative (the “Representative”), on a best efforts basis, an aggregate of up to 6,695,652 common
shares (the “Shares”), no par value (the “Common Shares”). 

 

In consideration of the mutual agreements
contained herein and of the interests of the parties in the transactions contemplated hereby, the parties hereto agree as follows:

 

1.                  
Representations and Warranties of the Company. The Company represents and warrants to each of the Underwriters as
follows:

 

(a)       The Company has filed with
the Commission a registration statement on Form F-3 (No. 333-226949) including a related prospectus, covering the public offering
and sale of up to $15,000,000 of its common shares, warrants, units and common share purchase rights from time to time pursuant
to Rule 415 under the Act (as defined below), which registration statement was declared effective by the Commission on September
5, 2018. “Registration Statement” at any particular time means such registration statement in the form then
filed with the Commission, including any amendment thereto, any document incorporated by reference therein and all 430B Information
and all 430C Information with respect to such registration statement, that in any case has not been superseded or modified. Any
reference to Registration Statement without reference to a time means the Registration Statement as of the Effective Time. For
purposes of this definition, 430B Information shall be considered to be included in the Registration Statement as of the time specified
in Rule 430B. 

 

For purposes
of this Agreement:

 

“430B
Information” with respect to any registration statement, means information included in a prospectus then deemed to be
a part of such registration statement pursuant to Rule 430B(e) or retroactively deemed to be part of such registration statement
pursuant to Rule 430B(f).

 

    -1-

    

    

“430C
Information” with respect to any registration statement, means information included in a prospectus then deemed to be
part of such registration statement pursuant to Rule 430C.

 

“Act”
means the U.S. Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Applicable
Time” means 6:00 A.M. (Eastern time) on the date of this Agreement.

 

“Closing
Date” has the meaning defined in Section 2 hereof.

 

“Commission”
means the U.S. Securities and Exchange Commission.

 

“Effective
Time” of the Registration Statement relating to the Shares means the time of the first contract of sale of the Shares.

 

“Exchange
Act” means the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Final
Prospectus” means the Statutory Prospectus that discloses the public offering price, other 430B Information and other
final terms of the Shares and otherwise satisfies Section 10(a) of the Act.

 

“General
Use Free Writing Prospectus” means any Issuer Free Writing Prospectus that is intended for general distribution to prospective
investors, as evidenced by it being so specified in Schedule II to this Agreement.

 

“Issuer
Free Writing Prospectus” means any “issuer free writing prospectus,” as defined in Rule 433, relating to
the Shares in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained
in the Company’s records pursuant to Rule 433(g).

 

“Limited
Use Free Writing Prospectus” means any Issuer Free Writing Prospectus that is not a General Use Free Writing Prospectus.

 

“Statutory
Prospectus” with reference to a particular time means the prospectus relating to the Shares that is included in a Registration
Statement immediately prior to that time, including any document incorporated by reference therein and any 430B Information and
all 430C Information. For purposes of the foregoing definition, 430B Information shall be considered to be included in the Statutory
Prospectus only as of the actual time that a form of prospectus (including a prospectus supplement) is filed with the Commission
pursuant to Rule 424(b) and not retroactively.

 

“Significant
Subsidiary” means a “Significant Subsidiary” as defined in Rule 405.

 

“Subsidiary”
means a corporation, general partnership, limited partnership, limited liability limited partnership, limited liability company
or other entity, a majority of the outstanding voting or capital stock, partnership, membership or other voting or equity interests
or general, limited or limited liability limited partnership interests, as the case may be, of which is majority owned or controlled,
directly or indirectly, by the Company, or one or more other Subsidiaries of the Company.

 

    -2-

    

    

Unless otherwise
specified, a reference to a “rule” or “Rule” is to the indicated rule under the Act.

 

(b)       (A)
(1) At the time the Registration Statement initially became effective, (2) at the time of each amendment thereto for the purposes
of complying with Section 10(a)(3) of the Act (whether by post-effective amendment, incorporated report or form of prospectus),
(3) at the Effective Time and (4) on each Closing Date, the Registration Statement complied and will comply in all material respects
to the requirements of the Act, and did not and will not include any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading, and (B) (1) on its date, (2) at the time of filing of the Final Prospectus pursuant to Rule 424(b) and
(3) on each Closing Date, the Final Prospectus will comply in all material respects to the requirements of the Act and will not
include any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to
make the statements therein, in light of the circumstances under which they were made, not misleading. The preceding sentence does
not apply to statements in or omissions from any such document based upon written information furnished to the Company by any Underwriter
specifically for use therein, it being understood and agreed that such information is only that described as such in Section
11 hereof.

 

(c)       The
Registration Statement is effective under the Act and no stop order preventing or suspending the effectiveness of the Registration
Statement has been issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the
Company, are threatened by the Commission.  At the time the Registration Statement was filed with, and declared effective
by, the Commission, the Company was eligible to register the Shares on Form F-3 promulgated under the Act, and as of the date
hereof, remains eligible to use the Registration Statement pursuant to General Instruction I.B.1 of Form F-3. As of the
close of trading on the NYSE American (“NYSE American”) on December 13, 2019, the aggregate market value of
the outstanding voting and non-voting common equity (as defined in Rule 405) of the Company held by persons other than affiliates
of the Company (pursuant to Rule 144 of the Act, those that directly, or indirectly through one or more intermediaries, control,
or are controlled by, or are under common control with, the Company) (the “Non-Affiliate Shares”), was approximately
$114,538,945 (calculated by multiplying (x) the price at which the common shares of the Company were last sold on NYSE American
on December 13, 2019 times (y) the number of Non-Affiliate Shares). The date of this Agreement is not more than three years subsequent
to the initial effective time of the Registration Statement.

 

(d)       As
of the Applicable Time, none of (A) the General Use Free Writing Prospectus(es) issued at or prior to the Applicable Time, if any,
and the prospectus supplement, dated December 16, 2019, including the base prospectus, filed August 20, 2018, and the other information,
if any, stated in Schedule II to this Agreement, all considered together (collectively, the “General
Disclosure Package”) and (B) any individual Limited Use Free Writing Prospectus, when considered together with the General
Disclosure Package, included any untrue statement of a material fact or omitted to state any material fact necessary in order to
make the statements therein, in the light of the circumstances under which they were made, not misleading. The preceding sentence
does not apply to statements in or omissions from any Statutory Prospectus or any Issuer Free Writing Prospectus in reliance upon
and in conformity with written information furnished to the Company by any Underwriter specifically for use therein, it being understood
and agreed that such information furnished by any Underwriter consists of only the information described as such in Section
11 hereof.

 

    -3-

    

    

(e)       The
documents incorporated by reference into the Registration Statement, the General Disclosure Package and the Final Prospectus, at
the time they were filed with the Commission (collectively, the “Incorporated Documents”), complied in all material
respects with the requirements of the Exchange Act. Each such Incorporated Document, when taken together with the General Disclosure
Package, did not as of the Applicable Time contain any untrue statement of a material fact or omitted to state any material fact
required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were
made, not misleading.

 

(f)       Each
Issuer Free Writing Prospectus, as of its issue date and at all subsequent times through the completion of the public offer and
sale of the Shares or until any earlier date that the Company notified or notifies the Representative as described in the next
sentence, did not, does not and will not include any information that conflicted, conflicts or will conflict with the information
then contained in the Registration Statement. If at any time following the issuance of an Issuer Free Writing Prospectus, at a
time when a prospectus relating to the Shares is (or but for the exemption in Rule 172 would be) required to be delivered
under the Act by any Underwriter or dealer, there occurred or occurs an event or development as a result of which such Issuer Free
Writing Prospectus conflicted or would conflict with the information then contained in the Registration Statement or as a result
of which such Issuer Free Writing Prospectus, if republished immediately following such event or development, would include an
untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading, (i) the Company has promptly notified or
will promptly notify the Representative and (ii) the Company has promptly amended or will promptly amend or supplement such Issuer
Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission. This section does not apply to statements
in or omissions from any Issuer Free Writing Prospectus in reliance upon and in conformity with written information furnished to
the Company by any Underwriter specifically for use therein, it being understood and agreed that such information furnished by
any Underwriter consists of only the information described as such in Section 11 hereof.

 

(g)       The
Company has full legal right, power and authority to enter into this Agreement and perform the transactions contemplated hereby.
This Agreement has been duly authorized, executed and delivered by the Company and is a legal, valid and binding agreement of the
Company enforceable in accordance with its terms, except to the extent that (i) enforceability may be limited by bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting creditors’ rights generally and by general equitable principles and
(ii) the indemnification and contribution provisions may be limited by federal or state securities laws or public policy considerations
in respect thereof.

 

(h)       The
Shares have been duly authorized for issuance and sale pursuant to this Agreement and, when issued and delivered by the Company,
against payment therefor pursuant to this Agreement, will be validly issued, fully paid and nonassessable, and the issuance and
sale of the Shares is not subject to any preemptive rights, rights of first refusal or other similar rights to subscribe for or
purchase the Shares which have not been duly withdrawn, waived or satisfied. Upon the sale and delivery through the Underwriters
of the Shares, and payment therefor, the Underwriters will acquire good, marketable and valid title to such Shares, free and clear
of all pledges, liens, security interests, charges, claims or encumbrances. The Shares, when issued, will conform to the description
thereof set forth in or incorporated into the Registration Statement, General Disclosure Package and Final Prospectus.

    -4-

    

    

 

(i)        Except as otherwise disclosed in the Registration Statement, the General Disclosure Package and Final Prospectus (including
any Incorporated Documents), there are no persons with registration or other similar rights to have any equity or debt securities
registered for sale under the Registration Statement or included in the offering contemplated by this Agreement, except for such
rights as have been duly withdrawn or waived.

 

(j)        Except as otherwise disclosed in the Registration Statement, the General Disclosure Package and the Final Prospectus (including
any Incorporated Documents), subsequent to the respective dates as of which information is given in the Registration Statement,
the General Disclosure Package and the Final Prospectus, if any: (i) there has been no material adverse change, or any development
that could be expected to result in a material adverse change, in the condition, financial or otherwise, or in the earnings, business,
properties, operations, assets, liabilities or prospects, whether or not arising from transactions in the ordinary course of business,
of the Company and its Subsidiaries, considered as one entity (any such change being referred to herein as a “ Material
Adverse Change ”); (ii) the Company and its Subsidiaries, considered as one entity, have not incurred any material
liability or obligation, indirect, direct or contingent, including without limitation any losses or interference with its business
from fire, explosion, flood, earthquakes, accident or other calamity, whether or not covered by insurance, or from any strike,
labor dispute or court or governmental action, order or decree, that are material, individually or in the aggregate, to the Company
and its Subsidiaries, considered as one entity, or have entered into any transactions not in the ordinary course of business; and
(iii) there has not been any material decrease in the capital stock or any material increase in any long-term indebtedness
of the Company or its Subsidiaries and there has been no dividend or distribution of any kind declared, paid or made by the Company
or, except for dividends paid to the Company or other Subsidiaries, by any of the Company’s Subsidiaries on any class of
capital stock, or any repurchase or redemption by the Company or any of its Subsidiaries of any class of capital stock.

 

(k)       Dale Matheson Carr-Hilton Labonte LLP (the “Accountant”) has expressed its opinion with respect to the
financial statements (which term as used in this Agreement includes the related notes thereto) filed with the Commission as a part
of the Company’s Annual Report on Form 20-F for the fiscal year ended August 31, 2019, filed with the Commission and incorporated
by reference into the Registration Statement, the General Disclosure Package and the Final Prospectus. Dale Matheson Carr-Hilton
Labonte LLP is (i) an independent registered public accounting firm as required by the Securities Act, the Exchange Act, and
the rules of the Public Company Accounting Oversight Board (“ PCAOB ”), (ii) in compliance with the applicable
requirements relating to the qualification of accountants under Rule 2-01 of Regulation S-X under the Securities Act, (iii) a
registered public accounting firm as defined by the PCAOB whose registration has not been suspended or revoked and who has not
requested such registration to be withdrawn and (iv) an independent qualified public accountant qualified under the applicable
provisions of the Canadian Public Accounting Board and any rules promulgated thereunder.

 

    -5-

    

    

(l)        The
consolidated financial statements filed with the Commission and incorporated by reference into the Registration Statement, the
General Disclosure Package and the Final Prospectus, present fairly, in all material respects, the consolidated financial position
of the Company and its Subsidiaries as of the dates indicated and the results of their operations, changes in stockholders’
equity and cash flows for the periods specified. Such financial statements have been prepared in conformity with International
Financial Reporting Standards (“ IFRS ”) as issued by the International Accounting Standards Board (the “
IASB ”) and Interpretations of the International Financial Reporting Interpretations Committee (“ IFRIC
”), applied on a consistent basis throughout the periods involved, except as may be expressly stated in the related
notes thereto or as otherwise disclosed therein, and, in the case of interim financial statements, subject to normal year-end
audit adjustments and the exclusion of certain footnotes. No other financial statements or supporting schedules are required to
be included or incorporated by reference in the Registration Statement, the General Disclosure Package and the Final Prospectus.
To the Company’s knowledge, no person who has been suspended or barred from being associated with a registered public accounting
firm, or who has failed to comply with any sanction pursuant to Rule 5300 promulgated by the PCAOB, has participated in or otherwise
aided the preparation of, or audited, the financial statements, supporting schedules or other financial data filed with the Commission
as a part of the Registration Statement, the General Disclosure Package and the Final Prospectus.

 

(m)      The
Company and each of its Subsidiaries make and keep accurate books and records and maintain a system of internal accounting controls
designed to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general
or specific authorization; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity
with IFRS as issued by IASB and IFRIC and to maintain accountability for assets; (iii) access to assets is permitted only
in accordance with management’s general or specific authorization and (iv) the recorded accountability for assets is
compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences.

 

(n)       The
Company has established and maintains disclosure controls and procedures (as defined in Rules 13a-15 and 15d-15 under the
Exchange Act), which are designed to ensure that material information relating to the Company, including its consolidated Subsidiaries,
is made known to the Company’s principal executive officer and its principal financial officer by others within those entities
and are effective in all material respects to perform the functions for which they were established. Except as disclosed in the
Registration Statement, since the end of the Company’s most recent audited fiscal year, there has been no material weakness
in the Company’s internal control over financial reporting (whether or not remediated) and no change in the Company’s
internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s
internal control over financial reporting. The Company is not aware of any change in its internal control over financial reporting
that has occurred that has materially and adversely affected, or is reasonably likely to materially and adversely affect, the
Company’s internal control over financial reporting except as disclosed in the Registration Statement.

 

(o)       The Company has been duly incorporated and is validly existing under the Business Corporation Act (Alberta) Canada
and has the corporate power and authority to own, lease and operate its properties and to conduct its business as described in
the Registration Statement, the General Disclosure Package and the Final Prospectus and to enter into and perform its obligations
under this Agreement. The Company is duly qualified as a foreign corporation to transact business in each jurisdiction in which
such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business.

 

    -6-

    

    

(p)       Each of the Company’s Subsidiaries has been duly incorporated or organized, as the case may be, and is validly existing
as a corporation, partnership or limited liability company, as applicable, in good standing (where such concept exists) under the
laws of the jurisdiction of its incorporation or organization and has the power and authority (corporate or other) to own, lease
and operate its properties and to conduct its business as described in the Registration Statement, the General Disclosure Package
and the Final Prospectus. Each of the Subsidiaries is duly qualified as a foreign corporation, partnership or limited liability
company, as applicable, to transact business and is in good standing in each jurisdiction in which such qualification is required,
whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to be so qualified
or in good standing (where such concept exists) would not, individually or in the aggregate, result in a Material Adverse Change.
All of the issued and outstanding capital stock or other equity or ownership interests of each of the Subsidiaries have been duly
authorized and validly issued, are fully paid and nonassessable and are owned by the Company, directly or through Subsidiaries,
and, except as described in the Registration Statement, the General Disclosure Package and the Final Prospectus, free and clear
of any security interest, mortgage, pledge, lien, encumbrance or adverse claim. The Company does not own or control, directly or
indirectly, any corporation, association or other entity other than the Subsidiaries.

 

(q)       The authorized, issued and outstanding share capital of the Company is as set forth in the Registration Statement, the General
Disclosure Package and the Final Prospectus as of the dates referred to therein (other than for subsequent issuances, if any, pursuant
to employee benefit plans, or upon the exercise of outstanding options, warrants or conversion rights, in each case described in
the Registration Statement, the General Disclosure Package and the Final Prospectus). The share capital of the Company, including
the Shares, conforms in all material respects to the description thereof contained in the Registration Statement, the General Disclosure
Package and the Final Prospectus. All of the issued and outstanding Common Shares have been duly authorized and validly issued,
are fully paid and nonassessable. Except as described in the Registration Statement, the General Disclosure Package and the Final
Prospectus, none of the outstanding Common Shares was issued in violation of any preemptive rights, rights of first refusal or
other similar rights to subscribe for or purchase securities of the Company. The Common Shares conform to the law of the jurisdiction
of the Company’s incorporation and to any requirements of the Company’s organizational documents. There are no authorized
or outstanding options, warrants, preemptive rights, rights of first refusal or other rights to purchase, or equity or debt securities
convertible into or exchangeable or exercisable for, any capital stock of the Company or any of its Subsidiaries other than those
described in the Registration Statement, the General Disclosure Package and the Final Prospectus. The descriptions of the Company’s
stock option, stock bonus and other stock plans or arrangements, and the options or other rights granted thereunder, set forth
in the Registration Statement, the General Disclosure Package and the Final Prospectus accurately and fairly presents the information
required to be provided with respect to such plans, arrangements, options and rights.

 

(r)        The
Shares will have been approved for listing on the NYSE American.

 

    -7-

    

    

(s)       
Neither the Company nor any of its Subsidiaries is in violation of its articles of incorporation or operating agreement
or similar organizational documents, as applicable, or is in default (or, with the giving of notice or lapse of time, would be
in default) (“ Default ”) under any indenture, loan, credit agreement, note, lease, license agreement, contract,
franchise or other instrument (including, without limitation, any pledge agreement, security agreement, mortgage or other instrument
or agreement evidencing, guaranteeing, securing or relating to indebtedness) to which the Company or any of its Subsidiaries is
a party or by which it or any of them may be bound, or to which any of their respective properties or assets are subject (each,
an “ Existing Instrument ”), except (i) for such Defaults as would not be expected, individually or in the aggregate,
to have a Material Adverse Change, and (ii) as disclosed in the Registration Statement, the General Disclosure Package and the
Final Prospectus. The Company’s execution, delivery and performance of this Agreement, consummation of the transactions contemplated
hereby and by the Registration Statement, the General Disclosure Package and the Final Prospectus and the issuance and sale of
the Shares (including the use of proceeds from the sale of the Shares as described in the Registration Statement, the General Disclosure
Package and the Final Prospectus under the caption “Use of Proceeds”) (i) have been duly authorized by all necessary
corporate action and will not result in any violation of the provisions of the articles of association or operating agreement or
similar organizational documents, as applicable, of the Company or any Subsidiary (ii) will not conflict with or constitute
a breach of, or Default or a Debt Repayment Triggering Event (as defined below) under, or result in the creation or imposition
of any lien, charge or encumbrance upon any property or assets of the Company or any of its Subsidiaries pursuant to, or require
the consent of any other party to, any Existing Instrument and (iii) will not result in any violation of any law, administrative
regulation or administrative or court decree applicable to the Company or any of its Subsidiaries except, as to clauses (ii) and
(iii), as would not be expected, individually or in the aggregate, to have a Material Adverse Change. No consent, approval, authorization
or other order of, or registration or filing with, any court or other governmental or regulatory authority or agency, is required
for the Company’s execution, delivery and performance of this Agreement and consummation of the transactions contemplated
hereby and by the Registration Statement, the General Disclosure Package and the Final Prospectus, except such as have been obtained
or made by the Company and are in full force and effect under the Securities Act and such as may be required under applicable state
securities or blue sky laws, the Financial Industry Regulatory Authority (“ FINRA ”) or the Exchange. As used
herein, a “ Debt Repayment Triggering Event ” means any event or condition which gives, or with the giving of
notice or lapse of time would give, the holder of any note, debenture or other evidence of indebtedness (or any person acting on
such holder’s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness
by the Company or any of its Subsidiaries.

 

(t)        The
Company and its Subsidiaries have been and are in compliance with all applicable laws, rules and regulations, except where failure
to be so in compliance would not be expected, individually or in the aggregate, to have a Material Adverse Change. Each of the
Company and its Subsidiaries is not in violation of any provision of its articles of incorporation or by-laws.

 

(u)       Except as described in the Registration Statement, the General Disclosure Package and the Final Prospectus, there is no
action, suit, proceeding, inquiry or investigation brought by or before any governmental entity now pending or, to the knowledge
of the Company, threatened, against or affecting the Company or any of its Subsidiaries, which would be expected, individually
or in the aggregate, to have a Material Adverse Change or materially and adversely affect the consummation of the transactions
contemplated by this Agreement or the performance by the Company of its obligations hereunder; and the aggregate of all pending
legal or governmental proceedings to which the Company or any such Subsidiary is a party or of which any of their respective properties
or assets is the subject, including ordinary routine litigation incidental to the business, if determined adversely to the Company,
would not be expected to have a Material Adverse Change. No material labor dispute with the employees of the Company or any of
its Subsidiaries exists or, to the knowledge of the Company, is threatened or imminent.

 

(v)       
Except as described in the Registration Statement, the General Disclosure Package and the Final Prospectus, each of the
Company and its Subsidiaries owns, is licensed or otherwise had adequate rights to use Company technology (including, without limitation,
patented, patentable and unpatented inventions and unpatentable proprietary or confidential information, systems or procedures),
designs, processes, trademarks, trade secrets, know how, copyrights and other works of authorship, computer programs and technical
data and information that are or could reasonably be expected to be material to its business as currently conducted or as currently
proposed to be conducted, except to the extent that the failure to own, possess, license or otherwise hold adequate right to use
such Intellectual Property would not, individual, or in the aggregate have a Material Adverse Change.

 

    -8-

    

    

(w)      Except as described in the Registration Statement, the General Disclosure Package and the Final Prospectus, each of the
Company and its Subsidiaries has (i) all governmental and other regulatory licenses, permits, consents, orders, approvals
and other authorizations necessary to carry on its business as described in the Registration Statement, the General Disclosure
Package or the Prospectus; (ii) performed all obligations required to be performed by it, and is not in default under any
indenture, mortgage, deed of trust, voting trust agreement, loan agreement, bond, debenture, note agreement, lease or other agreement
or instrument (individually, a “ Contract ” and collectively, “ Contracts ”) to which it
is a party or by which its property is bound or affected, except, in each case, where the failure to do so or where such default
would not reasonably be expected to have a Material Adverse Change.  Each Contract was duly authorized, executed and delivered
by the Company or the relevant Subsidiary of the Company, constitutes valid and binding agreements of the Company or such Subsidiary
of the Company and are enforceable against the Company or such Subsidiary of the Company in accordance with the terms thereof,
except, in each case, where the failure to do so or where such default would not reasonably be expected to have a Material Adverse
Change.   To the knowledge of the Company, no other party under any Contract to which it or its Subsidiaries is a party
is in default in any respect thereunder. Neither the Company nor any of its Subsidiaries has sent or received any communication
regarding termination of, or intent not to renew, any of the Contracts and no such termination or non-renewal has been threatened
by the Company or any of its Subsidiaries or, to the Company’s knowledge, any other party to any such contract or agreement,
which threat of termination or non-renewal has not been rescinded as of the date hereof, except where such termination or non-renewal
would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Change.

 

(x)        Except as described in the Registration Statement, the General Disclosure Package and the Final Prospectus, the Company
and its Subsidiaries have good and marketable title to all of the real and personal property and other assets reflected as owned
in the financial statements referred to in Section 1(l) above (or elsewhere in the Registration Statement, the General Disclosure
Package or the Final Prospectus), in each case free and clear of any security interests, mortgages, liens, encumbrances, equities,
adverse claims and other defects, except as otherwise disclosed in the Registration Statement, the General Disclosure Package and
the Final Prospectus or as would not reasonably be expected to have a Material Adverse Change. The real property, improvements,
equipment and personal property held under lease by the Company or any of its Subsidiaries are held under valid and enforceable
leases, with such exceptions as are not material and do not materially interfere with the use made or proposed to be made of such
real property, improvements, equipment or personal property by the Company or such Subsidiary.

 

(y)       Except where the failure to do so would not constitute a Material Adverse Change, (a) all tax returns (including tax
refund requests) required to be filed pursuant to applicable law by or with respect to the Company and any of its Subsidiaries
have been timely filed, or proper request of extension thereof has been filed, and (b) all tax returns filed are complete
and correct, and all taxes, fines or penalties due including any interest and penalties, except tax deficiencies that the Company
or any of its Subsidiaries are contesting in good faith subject to applicable reserves, have been timely paid and fully reserved
against in the applicable financial statements referred to in Section 1(l). On each of the Applicable Time and Closing Date,
as applicable all stock transfer or other taxes (other than income taxes) which are required to be paid in connection with the
sale and transfer of the Shares to be sold hereunder will be, or will have been, fully paid or provided for by the Company and
all laws imposing such taxes will be or will have been fully complied with.

 

    -9-

    

    

(z)        Except as described in the Registration Statement, the General Disclosure Package and the Final Prospectus, each of the
Company and its Subsidiaries are insured with policies in such amounts and with such deductibles and covering such risks as the
Company believes are adequate and customary for companies engaged in similar industries including, but not limited to, policies
covering real and personal property owned or leased by the Company and its Subsidiaries against theft, damage, destruction, acts
of vandalism and earthquakes and policies covering the Company and its Subsidiaries for product liability claims and clinical trial
liability claims and such insurance is in full force and effect. The Company has no reason to believe that it or any of its Subsidiaries
will not be able (i) to renew its existing insurance coverage as and when such policies expire or (ii) to obtain comparable
coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that
would not be expected to have a Material Adverse Change. Neither the Company nor any of its Subsidiaries has been denied any insurance
coverage which it has sought or for which it has applied.

 

(aa)      Except as described in the Registration Statement, the General Disclosure Package and the Final Prospectus,

 

(i)           
The Buckreef Project in Tanzania, as described in the Registration Statement, the General Disclosure Package and the Final
Prospectus (“Material Property”), is the only resource property that is currently material to the Company in
which the Company or the Subsidiaries have an interest.

 

(ii)           
The Company, directly or through its Subsidiaries, holds an interest in fee or freehold title, mining leases, mining concessions,
mining claims, exploration permits, prospecting permits, participant interests, conventional property agreements, or proprietary
interests or rights, or other similar contractual rights recognized in the jurisdiction in which the Material Property are located,
in respect of the ore bodies and minerals located on the Material Property in which the Company (through the applicable subsidiary)
has an interest under valid, subsisting and enforceable title documents or other recognized and enforceable agreements, instruments,
contracts, arrangements or understandings, sufficient to permit the Company (through the applicable subsidiary) to explore for
the minerals relating thereto, and all such material documents, agreements, instruments, contracts, arrangements or understandings
in connection with the Material Property (“Material Property Agreements”) are valid and subsisting and enforceable
in accordance with their terms, except in each case where the failure to be so would not be reasonably expected to have a Material
Adverse Change.

 

(iii)           
All concessions, leases, property agreements and contracts, claims and permits relating to the Material Property in which
the Company (through the applicable subsidiary) has an interest or right have been validly granted, located, approved, executed
and/or recorded or filed in accordance with all applicable laws and are valid, subsisting and enforceable in all respects, except
in each case where the failure to be so would not be reasonably expected to have a Material Adverse Change.

 

    -10-

    

    

(iv)           
Except as disclosed in the Registration Statement, the General Disclosure Package and the Final Prospectus, the Company
(through the applicable Subsidiary) has, or reasonably anticipates receiving in due course, all necessary surface rights, access
rights and other necessary rights and interests relating to the Material Property in which the Company (through the applicable
subsidiary) has an interest granting the Company (through the applicable Subsidiary) the right and ability to explore for minerals,
ore and metals as are appropriate in view of the rights and interest therein of the Company or the applicable Subsidiary, with
only such exceptions as do not materially interfere with the current use made by the Company or the applicable Subsidiary of the
rights or interest so held, and each of the proprietary interests or rights and each of the Material Property Agreements is currently
in good standing in all respects in the name of the Company or the applicable Subsidiary, except where such failure to be so would
not reasonably be expected to have a Material Adverse Change.

 

(bb)     All
assessments or other work required to have been performed to date in relation to the material mining claims and mining rights
of the Company and the applicable Subsidiary in order to maintain their respective interests therein, if any, have been performed
to date and, except as disclosed in the Registration Statement, the General Disclosure Package and the Final Prospectus, the Company
and the applicable Subsidiary have complied in all respects with all applicable laws in this regard as well as with legal and
contractual obligations to third parties in this regard except in respect of mining claims and mining rights that the Company
and the applicable Subsidiary intend to abandon or relinquish and except for any non-compliance which would not either individually
or in the aggregate reasonably be expected to have a Material Adverse Change.

 

(cc)      Except as disclosed in the Registration Statement, the General Disclosure Package and the Final Prospectus, all mining operations
by the Company and its Subsidiaries on the Material Properties have for the past five (5) years been conducted with the exercise
of reasonable diligence, skill, care and prudence for mining operations in similar locations under similar circumstances.

 

(dd)     Schedule 6(dd) sets out each applicable technical report relating to the Material Property (the “Reports”)
as of the date of this Agreement. Each Report was at the time of filing compliant, in all material respects, with the requirements
of the provisions of NI 43-101 - Standards of Disclosure for Mineral Projects (“NI 43-101”). All scientific
and technical information disclosed in the Registration Statement, the General Disclosure Package and the Final Prospectus: (i)
is based upon information prepared by or under the supervision of, or approved by, a “qualified person” (as such term
is defined in NI 43-101) and (ii) was true, complete and accurate in all material respects at the time of filing. The Company made
available to the respective authors thereof prior to the issuance of all of the Reports, for the purpose of preparing the Reports,
as applicable, all information requested, and no such information contained any misrepresentation as at the time the relevant information
was made available. The Reports, as of their respective dates, accurately and completely set forth all material facts relating
to the Material Property, and as of the date hereof and the date of the Prospectus, there is no new material scientific or technical
information concerning any of the Material Property not included in the Reports. With respect to information set forth in the Registration
Statement, the General Disclosure Package and the Final Prospectus: (i) information relating to the Company’s estimates of
mineral reserves and resources as at the date they were prepared has been reviewed and verified by the Company or independent consultants
to the Company as being consistent with the Company’s mineral reserve and mineral resource estimates as at the date they
were prepared; (ii) the mineral reserve and mineral resource estimated have been prepared in accordance with Industry Guide 7 under
the Act and/or National Instrument 43-101 - Standards of Disclosure for Mineral Projects, as applicable, by or under the supervision
of a “qualified person” as defined therein; and (iii) the methods used in estimating the Company’s mineral reserves
and mineral resources are in accordance with accepted mineral reserve and mineral resource estimation practices.

 

    -11-

    

    

(ee)     Except as described in the Registration Statement, the General Disclosure Package and the Final Prospectus, and except as
would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Change:

 

(i)       
each of the Company and its Subsidiaries is in compliance in all material respects with all applicable federal, provincial, state,
municipal and local laws, statutes, ordinances, regulations and binding orders, directives and decisions rendered by any government
ministry, government department or administrative or regulatory agency, whether domestic or foreign, in each case, relating to
the protection of the environment, the processing, use, treatment, storage, disposal, discharge, transport or handling of any pollutants,
contaminants, chemicals, substances or industrial wastes classified as toxic or hazardous to human health or the environment (the
“Hazardous Substances”), or with respect to exposure to Hazardous Substances, occupational health and safety
(collectively, the “Environmental Laws”);

 

(ii)       
the Company and its Subsidiaries have all permits, licenses, authorizations and approvals required for their operations as currently
conducted under any applicable Environmental Law (“Environmental Permits”) and are in compliance with all terms
and conditions of each Environmental Permit;

 

(iii)        there are no pending or, to the Company’s knowledge, threatened administrative, regulatory or judicial actions, suits, demands,
claims, liens or proceedings against the Company or any of its Subsidiaries, relating to any alleged violation of or liability
under Environmental Law;

 

(iv)        neither the Company nor any of its Subsidiaries is subject to (A) any written demand, written notice of default, summons, notice
of judgment or commencement of proceedings with respect to any alleged violation of or liability arising under Environmental Laws;
or (B) any outstanding legal obligations to remedy, pay compensation, or make any payment in the nature of a fine in relation to
any violation of Environmental Laws; and

 

(v)        to the Company’s knowledge, there are no events or circumstances that would reasonably be expected to form the basis of an
order for clean-up or remediation, or an action, suit or proceeding by any private party or governmental body or agency, against
or affecting the Company or any of its Subsidiaries pursuant to any Environmental Laws.

 

    -12-

    

    

(ff)       Neither
the Company nor any of its Subsidiaries maintains or contributes to, or has any liability with respect to, a defined benefit plan
as defined in Section 3(35) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”). 
No plan maintained or contributed to by the Company that is subject to ERISA (an “ERISA Plan”) (or any trust
created thereunder) has engaged in a “prohibited transaction” within the meaning of Section 406 of ERISA or Section
4975 of the Internal Revenue Code of 1986, as amended (the “Code”) that could subject the Company or any of
its Subsidiaries to any material tax penalty on prohibited transactions and that has not adequately been corrected.

 

(gg)     The
Company is not, and will not be, either after receipt of payment for the Shares or after the application of the proceeds therefrom
as described under “Use of Proceeds” in the Registration Statement, the General Disclosure Package and the Final Prospectus,
required to register as an “investment company” under the Investment Company Act of 1940, as amended (the “Investment
Company Act”).

 

(hh)     Neither
the Company nor any of its Subsidiaries has taken, directly or indirectly (without giving any effect to the activities of the
Underwriters), any action designed to or that might cause or result in stabilization or manipulation of the price of the Common
Shares or of any “reference security” (as defined in Rule 100 of Regulation M under the Exchange Act (“Regulation
M”)) with respect to the Common Shares, whether to facilitate the sale or resale of the Shares or otherwise, and has
taken no action which would directly or indirectly violate Regulation M.

 

(ii)       There
are no business relationships or related-party transactions involving the Company or any of its Subsidiaries or any other person
required to be described in the Registration Statement, the General Disclosure Package and the Final Prospectus that have not
been described as required.

 

(jj)       All of the information provided to the Underwriters or to counsel for the Underwriters by the Company, its counsel, its
officers and directors to be used by the Underwriters in their filings with FINRA in connection with the offering of the Shares
is true, complete, and correct in all material respects, and any letters, filings or other supplemental information provided to
FINRA by the Company pursuant to FINRA Rules is true, complete and correct in all material respects.

 

(kk)     All
statistical, demographic and market-related data included in the Registration Statement, the General Disclosure Package and the
Final Prospectus are based on or derived from sources that the Company believes, to be reliable and accurate in all material respects.

 

(ll)        Neither the Company nor any of its Subsidiaries nor, to the Company’s knowledge, any employee or agent of the Company
or any Subsidiary, has made any contribution or other payment to any official of, or candidate for, any federal, state or foreign
office in violation of any law or of the character required to be disclosed in the Registration Statement, the General Disclosure
Package and the Final Prospectus.

 

    -13-

    

    

(mm)    Neither the Company nor any of its Subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee,
affiliate or other person acting on behalf of the Company or any of its Subsidiaries has, in the course of its actions for, or
on behalf of, the Company or any of its Subsidiaries (i) used any corporate funds for any unlawful contribution, gift, entertainment
or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any domestic
government official, “foreign official” (as defined in the U.S. Foreign Corrupt Practices Act of 1977, as amended,
and the rules and regulations thereunder (collectively, the “FCPA”) or employee from corporate funds; (iii) violated
or is in violation of any provision of the FCPA or any applicable non-U.S. anti-bribery statute or regulation; or (iv) made
any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any domestic government official,
such foreign official or employee; and the Company and its Subsidiaries and, to the knowledge of the Company, the Company’s
affiliates have conducted their respective businesses in compliance with the FCPA and have instituted policies and procedures designed
to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith.

 

(nn)     The
operations of the Company and its Subsidiaries are, and have been conducted at all times, in compliance with applicable financial
recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money
laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar applicable
rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Money
Laundering Laws”) and no action, suit or proceeding by or before any court or governmental agency, authority or body
or any arbitrator involving the Company or any of its Subsidiaries with respect to the Money Laundering Laws is pending or, to
the best knowledge of the Company, threatened.

 

(oo)     Neither
the Company nor any of its Subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee, affiliate
or person acting on behalf of the Company or any of its Subsidiaries is currently subject to any U.S. sanctions administered by
the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the Company will not directly
or indirectly use the proceeds from the sale of the Shares, or lend, contribute or otherwise make available such proceeds to any
Subsidiary, or any joint venture partner or other person or entity, for the purpose of financing the activities of or business
with any person, or impermissibly in any country or territory, that currently is the subject to any U.S. sanctions administered
by OFAC or in any other manner that will result in a violation by any person (including any person participating in the transaction
whether as underwriter, advisor, investor or otherwise) of U.S. sanctions administered by OFAC.

 

(pp)     Except pursuant to this Agreement, there is no broker, finder or other party that is entitled to receive from the Company
or any Subsidiary any brokerage or finder’s fee or other fee or commission as a result of any transactions contemplated by
this Agreement.

 

(qq)     Each
financial or operational projection or other “forward-looking statement” (as defined by Section 27A of the Securities
Act or Section 21E of the Exchange Act), if any, contained in the Registration Statement, the General Disclosure Package
and the Final Prospectus (i) was so included by the Company in good faith and with reasonable basis after due consideration
by the Company of the underlying assumptions, estimates and other applicable facts and circumstances and (ii) is accompanied
by meaningful cautionary statements identifying those factors that could cause actual results to differ materially from those
in such forward-looking statement. No such statement was made with the knowledge of an executive officer or director of the Company
that is was false or misleading.

 

(rr)       The
Company is a “foreign private issuer” within the meaning of Rule 405 under the Securities Act (“Foreign Private
Issuer”).

 

(ss)      Except as described in the Registration Statement, the General Disclosure Package and the Final Prospectus, no Subsidiary
of the Company is prohibited or restricted, directly or indirectly, from paying dividends to the Company, or from making any other
distribution with respect to such Subsidiary’s equity securities or from repaying to the Company or any other Subsidiary
of the Company any amounts that may from time to time become due under any loans or advances to such Subsidiary from the Company
or from transferring any property or assets to the Company or to any other Subsidiary.

 

    -14-

    

    

(tt)       Neither the Company nor any of the Subsidiaries (i) is required to register as a “broker” or “dealer”
in accordance with the provisions of the Exchange Act or (ii) directly or indirectly through one or more intermediaries, controls
or is a “person associated with a member” or “associated person of a member” (within the meaning set forth
in the FINRA Manual).

 

(uu)     The Company has not relied upon the Underwriters or legal counsel for the Underwriters for any legal, tax or accounting
advice in connection with the offering and sale of the Shares.

 

(vv)     There is and has been no failure on the part of the Company or any of the Company’s directors or officers, in their
capacities as such, to comply in all material respects with any applicable provisions of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley
Act”) and the rules and regulations promulgated thereunder. Each of the principal executive officer and the principal
financial officer of the Company (or each former principal executive officer of the Company and each former principal financial
officer of the Company as applicable) has made all certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act with
respect to all reports, schedules, forms, statements and other documents required to be filed by it or furnished by it to the Commission.
For purposes of the preceding sentence, “principal executive officer” and “principal financial officer”
shall have the meanings given to such terms in the Sarbanes-Oxley Act.

 

(ww)    Neither
the issuance, sale and delivery of the Shares nor the application of the proceeds thereof by the Company as described in the Registration
Statement, the General Disclosure Package and the Final Prospectus, will violate Regulation T, U or X of the Board of Governors
of the Federal Reserve System or any other regulation of such Board of Governors.

 

(xx)      The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified
in Rules 164 and 433 under the Securities Act in connection with the offering of the Shares.

 

(yy)     Each Issuer Free Writing Prospectus, as of its issue date and as of each Applicable Time, did not, does not and will not
include any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement,
the General Disclosure Package and the Final Prospectus, including any incorporated document deemed to be a part thereof that has
not been superseded or modified. The foregoing sentence does not apply to statements in or omissions from any Issuer Free Writing
Prospectus based upon written information furnished to the Company by any Underwriter specifically for use therein, it being understood
and agreed that such information is only that described as such in Section 11 hereof.

 

(zz)      As of August 31, 2019, the Company has not determined whether it may be deemed a “passive foreign investment company,”
as such term is defined in the Code. Neither the Company nor any Subsidiary of the Company has any knowledge that it is, or,
after giving effect to the offering, issuance and sale of the Shares hereunder and the application of the proceeds thereof, that
it will be, a “controlled foreign corporation” as defined by the Code.

 

    -15-

    

    

(aaa)   
Except as provided by laws or statutes generally applicable to transactions of the type described in this Agreement, neither
the Company nor any of its respective properties, assets or revenues has any right of immunity under Canadian or United States
law, from any legal action, suit or proceeding, from the giving of any relief in any such legal action, suit or proceeding, from
set-off or counterclaim, from the jurisdiction of any Canadian or United States federal court, from service of process, attachment
upon or prior judgment, or attachment in aid of execution of judgment, or from execution of a judgment, or other legal process
or proceeding for the giving of any relief or for the enforcement of a judgment, in any such court, with respect to its obligations,
liabilities or any other matter under or arising out of or in connection with this Agreement. To the extent that the Company or
any of its respective properties, assets or revenues may have or may hereafter become entitled to any such right of immunity in
any such court in which proceedings may at any time be commenced, the Company waives or will waive such right to the extent permitted
by law and has consented to such relief and enforcement as provided in Section 7(f) of this Agreement.

 

(bbb)   The Company has the power
to submit, and pursuant to Section 7(f) of this Agreement, has legally, validly, effectively and irrevocably submitted, to the
personal jurisdiction of each United States federal court and New York state court located in the State of New York, Borough of
Manhattan, in the City of New York, New York, U.S.A. (each, a “New York Court”), and the Company has the power
to designate, appoint and authorize, and pursuant to Section 7(f) of this Agreement, has legally, validly, effectively and irrevocably
designated, appointed and authorized the an agent for service of process in any action arising out of or relating to the Shares
or this Agreement or any of the transactions contemplated hereby in any New York Court, and service of process effected on such
authorized agent will be effective to confer valid personal jurisdiction over the Company as provided in Section 7(f) hereof.

 

The Company acknowledges that the Underwriters
and, for purposes of the opinions to be delivered pursuant to this Agreement, counsel to the Company and counsel to the Underwriters,
will rely upon the accuracy and truthfulness of the foregoing representations and hereby consents to such reliance.

 

2.        
Purchase, Sale and Delivery of the Shares.

 

(a)       On the basis of the representations,
warranties and covenants herein contained, and subject to the conditions herein set forth, the Company hereby appoints the Underwriters
as agents of the Company to use their “best efforts” to assist the Company in finding subscribers for the Offering,
and each Underwriter agrees, severally and not jointly, as agent of the Company, to offer and sell the Shares for the Company pursuant
to this Agreement at a price of $0.575 per share.

 

(b)       Subject
to the provisions of this Agreement, as compensation for the services rendered, on the Closing Date, the Underwriters shall receive
an amount equal to seven percent (7.0%) (the “Commission Rate”) of the aggregate gross proceeds received by
the Company for the sale of the Shares; provided, that the Commission Rate shall be reduced to four percent (4%) of the aggregate
gross proceeds received by the Company for the sale of Shares to investors introduced to the Underwriters by the Company. The Underwriters
shall allocate such fees as they mutually agree and such allocation shall be provided to the Company at or prior to the Closing
Date. The Underwriters agree that the foregoing compensation, together with any expense reimbursements payable hereunder, constitutes
all of the compensation that the Underwriters shall be entitled to receive in connection with the transactions contemplated by
this Agreement.

 

    -16-

    

    

(c)       The
Underwriters may retain other brokers or dealers (each, a “Subagent”) who are members in good standing of FINRA
and duly registered as broker-dealers under the Exchange Act and under the laws of any states in which the offering is conducted
(except where such registration is not required by law) to assist them and to act as subagents on their behalf in connection with
the offering, and may enter into agreements with such Subagent for the offer and sale of the Shares adopting such provisions of
this Agreement for the benefit of the Subagents as the Underwriters deem appropriate; provided, however, that the Company will
only be obligated to pay the Underwriters, in accordance with the terms of this Agreement, for their services rendered hereunder
and shall be under no obligation to make any payment of any kind to any such Subagent.

 

(d)       Payment for the Shares
to be sold hereunder is to be made in federal (same day) funds against delivery thereof to the Representative for the several accounts
of the Underwriters. Such payment and delivery are to be made through the facilities of The Depository Trust Company, New York,
New York, at 10:00 a.m., New York time, on a date that is no later than seven business days after the date of this Agreement as
you and the Company shall agree upon, such time and date being herein referred to as the “Closing Date”. As
used herein, “business day” means a day on which NYSE American is open for trading and on which banks in New
York are open for business and are not permitted by law or executive order to be closed.

 

(e)       Subject
to the provisions of this Agreement and the performance by the Company of all of its obligations to be performed hereunder, the
Underwriters agree to offer and sell the Securities for the Company on a best efforts basis. It is understood and agreed
that the Underwriters shall not and are under no obligation to purchase any Shares for their own account and that this Agreement
does not create any partnership, joint venture, or other similar relationship between or among the Underwriters and the Company.
The Company recognizes that “best efforts” does not assure that the Offering will be consummated.

 

3.         Offering by the Underwriters.

 

It is understood that the several Underwriters
propose to offer the Shares to the public as set forth in the Final Prospectus. The Representative may from time to time thereafter
change the public offering price and other selling terms, subject to the Company’s written approval. It is further understood
that you will act as the Representative for the Underwriters in the offering and sale of the Shares.

 

4.         Covenants of the Company. The Company covenants and agrees with the several Underwriters that:

 

(a)       The
Company has filed or will (A) prepare and timely file with the Commission under Rule 424(b) under the Act each Statutory Prospectus
(including the Final Prospectus) in a form approved by the Representative, and (B) not file any amendment to the Registration Statement
or distribute an amendment or supplement to the General Disclosure Package or the Final Prospectus or document incorporated by
reference therein of which the Representative shall not previously have been advised and furnished with a copy or to which the
Representative shall have reasonably objected in writing or which is not in compliance with the Act.

 

(b)       The
Company will (i) not make any offer relating to the Shares that would constitute an Issuer Free Writing Prospectus or that would
otherwise constitute a “free writing prospectus” (as defined in Rule 405 under the Act) required to be filed by the
Company with the Commission under Rule 433 under the Act unless the Representative approves its use in writing prior to first use
(each, a “Permitted Free Writing Prospectus”); provided that the prior written consent of the Representative
hereto shall be deemed to have been given in respect of the Issuer Free Writing Prospectus(es) included on Schedule II hereto,
(ii) treat each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, (iii) comply with the requirements of Rules
164 and 433 under the Act applicable to any Issuer Free Writing Prospectus, including the requirements relating to timely filing
with the Commission, legending and record keeping and (iv) not take any action that would result in an Underwriter or the Company
being required to file with the Commission pursuant to Rule 433(d) under the Act a free writing prospectus prepared by or on behalf
of such Underwriter that such Underwriter otherwise would not have been required to file thereunder.

 

    -17-

    

    

(c)       The
Company will advise the Representative promptly (A) of receipt of any comments from the Commission, (B) when any supplement to
any Statutory Prospectus, any Issuer Free Writing Prospectus, or any amendment to the Final Prospectus has been filed, (C) of any
request of the Commission for amendment of the Registration Statement or for supplement to the General Disclosure Package or any
Statutory Prospectus or for any additional information, (D) of the issuance by the Commission of any stop order suspending the
effectiveness of the Registration Statement or any order preventing or suspending the use of any Statutory Prospectus, any Issuer
Free Writing Prospectus, the Final Prospectus, or of the institution of any proceedings for that purpose or pursuant to Section
8A of the Act, (E) of the occurrence of any event or development within the Prospectus Delivery Period as a result of which any
Statutory Prospectus, the General Disclosure Package, any Issuer Free Writing Prospectus, or Final Prospectus, as then amended
or supplemented would include any untrue statement of a material fact or omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances existing when any Statutory Prospectus, the General Disclosure Package,
any such Issuer Free Writing Prospectus or Final Prospectus is delivered to a purchaser, not misleading, and (F) of the receipt
by the Company of any notice with respect to any suspension of the qualification of the Shares for offer and sale in any jurisdiction
or the initiation or, to the knowledge of the Company, threatening of any proceeding for such purpose. The Company will use its
best efforts to prevent the issuance of any order referred to in clause (D) or (F) of this paragraph and to obtain as soon as possible
the lifting thereof, if issued.

 

(d)       The
Company will cooperate with the Representative in endeavoring to qualify the Shares for sale under the securities laws of such
jurisdictions as the Representative may reasonably have designated in writing and will make such applications, file such documents,
and furnish such information as may be reasonably required for that purpose; provided that the Company shall not be required
to (x) qualify as a foreign corporation, (y) file a general consent to service of process in any jurisdiction where it is not now
so qualified or required to file such a consent, or (z) subject itself to taxation in any such jurisdiction if it is not otherwise
so subject. The Company will, from time to time, prepare and file such statements, reports, and other documents, as are or may
be required to continue such qualifications in effect for so long a period as the Representative may reasonably request for distribution
of the Shares.

 

(e)       The
Company will deliver to, or upon the order of, the Representative, from time to time, as many copies of any Statutory Prospectus
as the Representative may reasonably request. The Company will deliver to, or upon the order of, the Representative, from time
to time, as many copies of any Issuer Free Writing Prospectus as the Representative may reasonably request. The Company will deliver
to, or upon the order of, the Representative during the period when delivery of a Statutory Prospectus (or, in lieu thereof, the
notice referred to under Rule 173(a) under the Act) (the “Prospectus Delivery Period”) is required under the
Act, as many copies of the Statutory Prospectus in final form, or as thereafter amended or supplemented, as the Representative
may reasonably request.

 

    -18-

    

    

(f)       The
Company will comply with the Act and the Exchange Act, so as to permit the completion of the distribution of the Shares as contemplated
in this Agreement and the Final Prospectus. If during the period in which a prospectus (or, in lieu thereof, the notice referred
to under Rule 173(a) under the Act) is required by law to be delivered by an Underwriter or dealer, any event or development shall
occur as a result of which, in the judgment of the Company or in the reasonable opinion of the Underwriters, it becomes necessary
to amend or supplement any Statutory Prospectus or the General Disclosure Package in order to make the statements therein, in the
light of the circumstances existing at the time the Statutory Prospectus or General Disclosure Package is delivered to a purchaser,
not misleading in any material respect, or, if it is necessary at any time to amend or supplement any Statutory Prospectus or the
General Disclosure Package to comply with any law, the Company promptly will either (i) prepare and file with the Commission an
appropriate amendment to the Registration Statement or supplement to any Statutory Prospectus or General Disclosure Package, or
(ii) prepare and file with the Commission an appropriate filing under the Exchange Act which shall be incorporated by reference
in the Final Prospectus so that the Final Prospectus as so amended or supplemented will not, in the light of the circumstances
when it is so delivered, be misleading in any material respect, or so that the Final Prospectus will comply with the law.

 

(g)       The
Company will make generally available to its security holders, as soon as it is practicable to do so, but in any event not later
than 15 months after the effective date of the Registration Statement, an earning statement (which need not be audited) in reasonable
detail, covering a period of at least 12 consecutive months beginning after the effective date of the Registration Statement, which
earning statement shall satisfy the requirements of Section 11(a) of the Act and Rule 158 under the Act and will advise you in
writing when such statement has been so made available.

 

(h)       Prior
to the Closing Date, the Company will furnish to the Underwriters, as soon as they have been prepared by or are available to the
Company (in the Company’s ordinary course of business), a copy of any unaudited interim financial statements of the Company
for any period subsequent to the period covered by the most recent financial statements appearing in the Registration Statement,
the General Disclosure Package and the Final Prospectus.

 

(i)       No offering, pledge, sale,
contract to sell, short sale or other disposition of any Common Shares of the Company or other securities convertible into or exchangeable
or exercisable for Common Shares or derivative of Common Shares (or agreement for such) will be made for a period starting after
the date of the Final Prospectus and extending to, but not including, January 30, 2020, directly or indirectly, by the Company
otherwise than hereunder or with the prior written consent of the Representative. Notwithstanding the foregoing, the Company may
(i) sell the Shares to the Underwriters, (ii) issue Common Shares upon exercise, conversion, or exchange of option or other securities,
(iii) file one or more registrations statements registering the secondary sale of Common Shares or securities convertible into
or exchangeable or exercisable for Common Shares, (iv) issue Common Shares, options to purchase Common Shares or restricted stock
units or similar equity securities pursuant to any stock option, stock bonus or other stock plan or arrangement described in the
Registration Statement or Final Prospectus or to be adopted by the Company and its shareholders, (v) issue Common Shares, options,
restricted stock units or similar equity securities to the Company’s directors as compensation for their services as directors,
(vi) enter into agreements providing for the issuance by the Company of Common Shares or any security convertible into or exchangeable
or exercisable for Common Shares in connection with the acquisition by the Company or any of its subsidiaries of the securities,
business, property or other assets of another person or entity (including pursuant to an employee benefit plan assumed by the Company
in connection with such acquisition), and issue any such securities pursuant to any such agreement, and (vii) enter into agreements
providing for the issuance of Common Shares or any security convertible into or exercisable for Common Shares in connection with
joint ventures, commercial relationships, debt financing or other strategic transactions, and issue any such securities pursuant
to any such agreements.

 

    -19-

    

    

(j)       The
Company shall maintain the listing of the Shares, subject to notice of issuance, on the NYSE American.

 

(k)       Intentionally
omitted.

 

(l)       The
Company shall apply the net proceeds of its sale of the Shares substantially in the manner described under the caption “Use
of Proceeds” in the Registration Statement, the General Disclosure Package and the Final Prospectus.

 

(m)       The
Company shall not invest, or otherwise use the proceeds received by the Company from its sale of the Shares in such a manner as
would require the Company or any of the Subsidiaries to register as an investment company under the Investment Company Act.

 

(n)       The
Company will maintain a transfer agent and, if necessary under the jurisdiction of incorporation of the Company, a registrar for
the Common Shares.

 

(o)       The
Company will not take, directly or indirectly, any action designed to cause or result in, or that has constituted or might reasonably
be expected to constitute, the stabilization or manipulation of the price of any securities of the Company.

 

5.         
Costs and Expenses.

 

The Company will pay all costs, expenses and
fees incident to the performance of the obligations of the Company under this Agreement, including, without limiting the generality
of the foregoing, the following: (i) accounting fees of the Company; (ii) the fees and disbursements of counsel for the Company;
(iii) all costs and expenses related to the transfer and delivery of the Shares to the Underwriters, including any transfer or
other taxes payable thereon; (iv) any roadshow expenses; (v) the cost of printing and delivering to, or as requested by, the Underwriters
copies of the Registration Statement, any Statutory Prospectuses, the Issuer Free Writing Prospectuses, the Final Prospectus, this
Agreement, the listing application, any Blue Sky survey, in each case, any supplements or amendments thereto; (vi) the filing fees
of the Commission; (vii) the filing fees and reasonable and documented expenses (including related fees and expenses of counsel
for the Underwriter) incident to securing any required review by FINRA of the terms of the sale of the Shares; (viii) all expenses
and application fees related to the listing of the Shares on NYSE American; (ix) the cost of printing certificates, if any, representing
the Shares; (x) the costs and charges of any transfer agent, registrar or depositary; (xi) the reasonable and documented expenses
of the Underwriter, including the related fees and disbursements of counsel for the Underwriters, incident to the offer and sale
of the Shares under this Agreement by the Underwriter, and (xii) the reasonable and documented expenses, including the related
fees and expenses of counsel for the Underwriters, incurred in connection with the qualification of the Shares under foreign or
state securities or Blue Sky laws and the preparation, printing and distribution of a Blue Sky memorandum. Notwithstanding the
foregoing, in no event shall the amount of expenses reimbursed to the Underwriters in connection with clauses (vii), (xi) and (xii)
above exceed $21,500 in the aggregate.

 

6.         
Conditions of Obligations of the Underwriters.

 

The several obligations of the Underwriters
hereunder are subject to the accuracy, as of the Applicable Time and the Closing Date, as the case may be, of the representations
and warranties of the Company contained herein, and to the performance by the Company of its covenants and obligations hereunder
and to the following additional conditions:

 

    -20-

    

    

(a)       The Final
Prospectus shall have been filed with the Commission in accordance with the Rule 424(b) under the Act. Prior to the Closing Date,
no stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose
shall have been instituted or, to the knowledge of the Company or the Underwriters, shall be contemplated by the Commission.

 

(b)       The Representative
shall have received on the Closing Date, (i) a written opinion and negative assurance letter of Lewis Brisbois Bisgaard & Smith
LLP, United States counsel to the Company (“U.S. Company Counsel”), (ii) the written legal opinion of Miller
Thomson LLP , Canadian counsel to the Company (“Canadian Company Counsel”), and (iii) the written legal opinion
of KNR Legal, Tanzanian counsel to the Company (“Tanzanian Company Counsel”).

 

(c)       The Representative
shall have received on each of the date hereof and the Closing Date, as the case may be, a letter or letters, in form and substance
satisfactory to you, of the Company’s mineralization engineers with respect to the Reports.

 

(d)       You shall
have received, on the Closing Date, a letter dated the date of the Closing Date, in form and substance satisfactory to you, of
the Accountant confirming that they are an independent registered public accounting firm with respect to the Company and the Subsidiaries
within the meaning of the Act and the PCAOB and stating that in their opinion the financial statements and schedules examined by
them and included or incorporated by reference in the Registration Statement, the General Disclosure Package and the Final Prospectus
comply in form in all material respects with the applicable accounting requirements of the Act; and containing such other statements
and information as is ordinarily included in accountants’ “comfort letters” to underwriters with respect to the
financial statements and certain financial and statistical information contained in the Registration Statement, the General Disclosure
Package and the Final Prospectus.

 

(e)       The Representative
shall have received on the Closing Date a certificate or certificates of the Chief Executive Officer and the Chief Financial Officer
of the Company to the effect that, as of the Closing Date, each of them severally represents as follows:

 

            (i)       The Registration Statement has become effective
under the Act and no stop order suspending the effectiveness of the Registration Statement or no order preventing or suspending
the use of any Statutory Prospectus, any Issuer Free Writing Prospectus or the Final Prospectus has been issued, and no proceedings
for such purpose or pursuant to Section 8A of the Act have been taken or are, to his or her knowledge, contemplated or threatened
by the Commission;

 

            (ii)      The representations and warranties of the
Company contained in Section 1 hereof are true and correct as of the Closing Date; and

 

            (iii)      For the period from and including the date
of this Agreement through and including such date, there has not been any material adverse change or any change or development,
that individually or in the aggregate, would reasonably be expected to have a material adverse change in the business, management,
properties, assets, rights, op-erations, condition (financial or otherwise) or prospects of the Company and the Subsidiaries taken
as a whole, whether or not arising in the ordinary course of business, except as set forth in the General Disclosure Package and
the Final Prospectus.

 

    -21-

    

    

(f)       The
Company shall have furnished to the Representative such further certificates and documents confirming the representations and warranties,
covenants and conditions contained herein and related matters as the Representative may reasonably have requested.

 

(g)       The
Company shall have submitted a listing of additional shares notification form to NYSE American with respect to the Shares and shall
have received no objection thereto from NYSE American.

 

(h)       No
action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any federal,
state or foreign governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or sale of the Shares
by the Company; and no injunction or order of any federal, state or foreign court shall have been issued that would, as of the
Closing Date, prevent the issuance or sale of the Shares by the Company.

 

The opinions and certificates mentioned in
this Agreement shall be deemed to be in compliance with the provisions hereof only if they are in all material respects reasonably
satisfactory to the Representative and to Michael Best & Friedrich LLP, counsel for the Underwriters.

 

If any of the conditions hereinabove provided
for in this Section 6 shall not have been fulfilled when and as required by this Agreement to be fulfilled, the obligations
of the Underwriters hereunder may be terminated by the Representative by notifying the Company of such termination in writing or
by telegram at or prior to the Closing Date.

 

In such event, the Company and the Underwriters
shall not be under any obligation to each other (except to the extent provided in Sections 5 and 7 hereof).

 

7.         Indemnification.

 

 (a)       The Company agrees:

 

(i)       to
indemnify and hold harmless each Underwriter, the directors and officers of each Underwriter and each person, if any, who controls
any Underwriter within the meaning of either Section 15 of the Act or Section 20 of the Exchange Act, against any losses, claims,
damages or liabilities to which such Underwriter or any such controlling person may become subject under the Act or otherwise,
insofar as such losses, claims, damages or liabilities (or actions or proceedings in respect thereof) arise out of or are based
upon (i) any untrue statement or alleged untrue statement of any material fact contained in the Registration Statement, any Statutory
Prospectus, any Issuer Free Writing Prospectus, the Final Prospectus or any amendment or supplement thereto, (ii) with respect
to the Registration Statement or any amendment or supplement thereto, the omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein not misleading or (iii) with respect to any Statutory
Prospectus, any Issuer Free Writing Prospectus, the Final Prospectus or any amendment or supplement thereto, the omission or alleged
omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading
in the light of the circumstances under which they were made; provided, however, that the Company will not be liable
in any such case to the extent that any such loss, claim, damage or liability (or action or proceeding in respect thereof) arises
out of or is based upon an untrue statement or alleged untrue statement, or omission or alleged omission made in the Registration
Statement, any Statutory Prospectus, any Issuer Free Writing Prospectus, the Final Prospectus, or such amendment or supplement,
in reliance upon and in conformity with written information furnished to the Company by or through the Representative specifically
for use therein, it being understood and agreed that the only such information furnished by any Underwriter consists of the information
described as such in Section 11 hereof; and

 

    -22-

    

    

(ii)       to
reimburse each Underwriter, each Underwriters’ directors and officers, and each such controlling person upon demand for any
documented legal or other out-of-pocket expenses reasonably incurred by such Underwriter or such controlling person in connection
with investigating or defending any such loss, claim, damage or liability, action or proceeding or in responding to a subpoena
or governmental inquiry related to the offering of the Shares, whether or not such Underwriter or controlling person is a party
to any action or proceeding. In the event that it is finally judicially determined that any such Underwriter, any such director
or officer or any such controlling person was not entitled to receive payments for legal and other expenses pursuant to this subparagraph,
then the Underwriters will promptly return all sums that had been advanced pursuant hereto.

 

(b)       Each Underwriter severally and not jointly will indemnify and hold harmless the Company, each of its directors, each of
its officers who have signed the Registration Statement, and each person, if any, who controls the Company within the meaning of
the Act, against any losses, claims, damages or liabilities to which the Company or any such director, officer, or controlling
person may become subject under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions or proceedings
in respect thereof) arise out of or are based upon (i) any untrue statement or alleged untrue statement of any material fact contained
in the Registration Statement, any Statutory Prospectus, any Issuer Free Writing Prospectus, the Final Prospectus or any amendment
or supplement thereto, (ii) with respect to the Registration Statement or any amendment or supplement thereto, the omission or
alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not
misleading or (iii) with respect to any Statutory Prospectus, any Issuer Free Writing Prospectus, the Final Prospectus or any amendment
or supplement thereto, the omission or alleged omission to state therein a material fact required to be stated therein or necessary
to make the statements therein not misleading in the light of the circumstances under which they were made; and will reimburse
any legal or other expenses reasonably incurred by the Company or any such director, officer, or controlling person in connection
with investigating or defending any such loss, claim, damage, liability, action or proceeding; provided, however,
that each Underwriter will be liable in each case to the extent, but only to the extent, that such untrue statement or alleged
untrue statement or omission or alleged omission has been made in the Registration Statement, any Statutory Prospectus, any Issuer
Free Writing Prospectus, the Final Prospectus or such amendment or supplement, in reliance upon and in conformity with written
information furnished to the Company by or through the Representative specifically for use therein, it being understood and agreed
that the only such information furnished by any Underwriter consists of the information described as such in Section 11
hereof. This indemnity agreement will be in addition to any liability which such Underwriter may otherwise have.

 

    -23-

    

    

(c)        In case any proceeding (including any governmental investigation) shall be instituted involving any person in respect of
which indemnity may be sought pursuant to this Section 7, such person (the “indemnified party”) shall
promptly notify the person against whom such indemnity may be sought (the “indemnifying party”) in writing.
No indemnification provided for in Section 7(a) or (b) hereof shall be available to any party who shall fail to give
notice as provided in this Section 7(c) if the indemnifying party was materially prejudiced by the failure to give such
notice, but the failure to give such notice shall not relieve the indemnifying party or parties from any liability which it or
they may have to the indemnified party for contribution or otherwise than on account of the provisions of Section 7(a) or
(b) hereof. In case any such proceeding shall be brought against any indemnified party and it shall notify the indemnifying
party of the commencement thereof, the indemnifying party shall be entitled to participate therein and, to the extent that it shall
wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel reasonably satisfactory
to such indemnified party and shall pay as incurred the reasonable and documented fees and disbursements of such counsel related
to such proceeding. In any such proceeding, any indemnified party shall have the right to retain its own counsel at its own expense.
Notwithstanding the foregoing, the indemnifying party shall pay as incurred (or within 30 days of presentation) the fees and expenses
of separate counsel retained by the indemnified party in the event (i) the indemnifying party and the indemnified party shall have
mutually agreed to the retention of such counsel, (ii) the named parties to any such proceeding (including any impleaded parties)
include both the indemnifying party and the indemnified party and representation of both parties by the same counsel would be inappropriate
due to actual or potential conflicts of interests between them or (iii) the indemnifying party shall have failed to assume the
defense and employ counsel reasonably acceptable to the indemnified party within a reasonable period of time after notice of commencement
of the action. Such separate counsel shall be designated in writing by you in the case of parties indemnified pursuant to Section
7(a) hereof and by the Company in the case of parties indemnified pursuant to Section 7(b) hereof. The indemnifying
party shall not be liable for any compromise or settlement of any pending or threatened claim, action or proceeding, or for any
consent to the entry of any judgment in any pending or threatened claim, action or proceeding, in each case effected without its
written consent but if settled or compromised with such written consent of the indemnifying party or if there be a final judgment
for the plaintiff, the indemnifying party agrees to indemnify the indemnified party from and against any loss or liability by reason
of such settlement, compromise or judgment. In addition, the indemnifying party will not, without the prior written consent of
the indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action
or proceeding of which indemnification may be sought hereunder (whether or not any indemnified party is an actual or potential
party to such claim, action or proceeding) unless such settlement, compromise or consent (i) includes an unconditional release
of each indemnified party from all liability arising out of such claim, action or proceeding and (ii) does not include a statement
as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party. If at any time an indemnified
party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel to which it
is entitled to be reimbursed under this Section 7, such indemnifying party agrees that it shall be liable for any settlement
of any proceeding effected without its written consent if (i) such settlement is entered into more than 60 days after receipt by
such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such
settlement at least 45 days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed
such indemnified party in accordance with such request and the other provisions of this Section 7 prior to the date of such
settlement.

 

(d)       To the extent the indemnification provided for in this Section 7 is unavailable to or insufficient to hold harmless
an indemnified party under Section 7(a) or (b) hereof in respect of any losses, claims, damages or liabilities (or
actions or proceedings in respect thereof) referred to therein, then each indemnifying party shall contribute to the amount paid
or payable by such indemnified party as a result of such losses, claims, damages or liabilities (or actions or proceedings in respect
thereof) in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the
Underwriters on the other from the offering of the Shares. If, however, the allocation provided by the immediately preceding sentence
is not permitted by applicable law then each indemnifying party shall contribute to such amount paid or payable by such indemnified
party in such proportion as is appropriate to reflect not only such relative benefits but also the relative fault of the Company
on the one hand and the Underwriters on the other in connection with the statements or omissions which resulted in such losses,
claims, damages or liabilities (or actions or proceedings in respect thereof), as well as any other relevant equitable considerations.
The relative benefits received by the Company on the one hand and the Underwriters on the other shall be deemed to be in the same
proportion as the net proceeds from the offering (before deducting expenses) received by the Company bear to the total underwriting
discounts and commissions received by the Underwriters, in each case as set forth in the table on the cover page of the Final Prospectus.
The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a
material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company on the
one hand or the Underwriters on the other and the parties’ relative intent, knowledge, access to information and opportunity
to correct or prevent such statement or omission.

 

    -24-

    

    

(e)        The Company, and the Underwriters agree that it would not be just and equitable if contributions pursuant to this Section
7(e) were determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any
other method of allocation which does not take account of the equitable considerations referred to above in this Section 7(e).
The amount paid or payable by an indemnified party as a result of the losses, claims, damages or liabilities (or actions or proceedings
in respect thereof) referred to above in this Section 7(e) shall be deemed to include any legal or other expenses reasonably incurred
by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions
of this Section 7(e), (i) no Underwriter shall be required to contribute any amount in excess of the underwriting discounts
and commissions applicable to the Shares purchased by such Underwriter, and (ii) no person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. The Underwriters’ obligations in this Section 7(e) to contribute are several in proportion to their
respective underwriting obligations and not joint.

 

(f)       
In any proceeding relating to the Registration Statement, any Statutory Prospectus, any Issuer Free Writing Prospectus,
the Final Prospectus or any supplement or amendment thereto, each party against whom contribution may be sought under this Section
7 hereby consents to the exclusive jurisdiction of (i) the federal courts of the United States of America located in the City
and County of New York, Borough of Manhattan and (ii) the courts of the State of New York located in the City and County of New
York, Borough of Manhattan.

 

(g)        The
indemnity and contribution agreements contained in this Section 7 and the representations and warranties of the Company
set forth in this Agreement shall remain operative and in full force and effect, regardless of (i) any investigation made by or
on behalf of any Underwriter, its directors or officers or any person controlling any Underwriter, the Company, its directors
or officers or any persons controlling the Company, (ii) acceptance of any Shares and payment therefor hereunder, and (iii) any
termination of this Agreement. A successor to any Underwriter, its directors or officers or any person controlling any Underwriter,
or to the Company, its directors or officers, or any person controlling the Company, shall be entitled to the benefits of the
indemnity, contribution and reimbursement agreements contained in this Section 7.

 

8.         
Notices.

 

All notices, consents, approvals, waivers
or other communications (each, a “Notice”) required or permitted hereunder, except as herein otherwise specifically
provided, shall be in writing and shall be (i) delivered personally or by commercial messenger, (ii) sent via a recognized overnight
courier service, (iii) sent by registered or certified mail, postage pre-paid and return receipt requested, or (iv) sent by e-mail
or facsimile transmission, provided confirmation of receipt is received by sender and the original Notice is sent or delivered
contemporaneously by an additional method provided in this Section 8; in each case so long as such Notice is addressed to
the intended recipient thereof as set forth below. Any party may change its address specified below by giving each party Notice
of such change in accordance with this Section 8. Any Notice shall be deemed given upon actual receipt (or refusal of receipt).

 

    -25-

    

    

	To the Underwriters:	
        R.F. Lafferty & Co., Inc.

        40 Wall Street, 19th Floor

        New York, NY 10005

        Attention: Robert Hackel, Chief Operating
        Officer

        Email: rhackel@rflafferty.

         

	With a copy to (which shall not constitute notice):	
        Michael Best & Friedrich LLP

        170 South Main Street, Suite 1000

        Salt Lake City, UT 84101

        Attention: James R. Kruse

        email: jrkruse@michaelbest.com

         

	
        To the Company:

         

         

         

         

         

         

         

         

        With a copy to (which shall not constitute
        notice):
	
        Tanzanian Gold Corporation

        Bay Adelaide Center, East Tower

        22 Adelaide Street West, Suite 3400

        Toronto, Ontario M5H 4E3

        Attention: James Sinclair, Executive Chairman

        Email: j.sinclair@tangoldcorp.com

         

        Lewis Brisbois Bisgaard & Smith LLP

        333 Bush Street, Suite 1100

        San Francisco, CA 94104

        Attn: Daniel B. Eng

        E-mail: Daniel.eng@lewisbrisbois.com

         

9.         
Termination.

 

(a)        This
Agreement may be terminated by the Representative by notice to the Company (a) at any time prior to the Closing Date if any of
the following has occurred: (i) since the respective dates as of which information is given in the Registration Statement, the
General Disclosure Package and the Final Prospectus, any material adverse change or any development, that individually or in the
aggregate, would reasonably be expected to have a material adverse change in the earnings, business, management, properties, assets,
rights, operations, condition (financial or otherwise) or prospects of the Company and the Subsidiaries taken as a whole, whether
or not arising in the ordinary course of business, except as set forth in the General Disclosure Package and the Final Prospectus;
(ii) any outbreak or escalation of hostilities or declaration of war or national emergency or other national or international
calamity or crisis (including, without limitation, an act of terrorism) or change in economic or political conditions if the effect
of such outbreak, escalation, declaration, emergency, calamity, crisis or change on the financial markets of the United States
would, in your judgment, materially impair the investment quality of the Shares; (iii) suspension of trading in securities generally
on the New York Stock Exchange or the NASDAQ Global Market or limitation on prices (other than limitations on hours or numbers
of days of trading) for securities on any such exchange; (iv) the enactment, publication, decree or other promulgation of any
statute, regulation, rule or order of any court or other governmental authority which in your opinion materially and adversely
affects or may materially and adversely affect the business or operations of the Company; (v) the declaration of a banking moratorium
by the United States or New York State authorities; (vi) any downgrading, or placement on any watch list for possible downgrading,
in the rating of any of the Company’s debt securities or preferred stock by any “nationally recognized statistical
rating organization” (within the meaning of Rule 15c3-1(c)(2)(vi)(F) under the Exchange Act) or any public announcement
by such organization that it has under surveillance or review, or has changed its outlook with respect to, its rating of any such
debt securities or preferred stock (other than an announcement with positive implications of a possible upgrading); or (vii) the
suspension of trading of the Company’s common stock by NYSE American, the Commission or any other governmental authority;
or (b) as provided in Section 6 of this Agreement.

 

    -26-

    

    

(b)       The Company may terminate this Agreement by written notice to the Representative if the closing has not occurred within
ten (10) business days after the date of this Agreement.

 

10.       
Successors.

 

This Agreement has been and is made solely
for the benefit of the Underwriters, the Company and their respective successors, executors, administrators, heirs and assigns,
and the officers, directors and controlling persons referred to herein, and no other person will have any right or obligation hereunder.
No purchaser of any of the Shares from any Underwriter shall be deemed a successor or assign merely because of such purchase.

 

11.      
Information Provided by Underwriters.

 

The Company and the Underwriters acknowledge and agree that the only
information furnished or to be furnished by any Underwriter to the Company for inclusion in the Registration Statement, any Statutory
Prospectus, any Issuer Free Writing Prospectus, or the Final Prospectus consists of the information set forth in the eighth paragraph
under the caption “Underwriting” in the Final Prospectus.

 

12.      
Miscellaneous.

 

The reimbursement, indemnification and contribution
agreements contained in this Agreement and the representations, warranties and covenants in this Agreement shall remain in full
force and effect regardless of (a) any termination of this Agreement, (b) any investigation made by or on behalf of any Underwriter
or controlling person thereof, or by or on behalf of the Company or its directors or officers, and (c) delivery of and payment
for the Shares under this Agreement.

 

The Company acknowledges and agrees that each
Underwriter in providing investment banking services to the Company in connection with the offering, including in acting pursuant
to the terms of this Agreement, has acted and is acting as an independent contractor and not as a fiduciary and the Company and
does not intend such Underwriter to act in any capacity other than as an independent contractor, including as a fiduciary or in
any other position of higher trust. Additionally, neither the Representative nor any other Underwriter is advising the Company
or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company shall consult
with their own advisors concerning such matters and shall be responsible for making their own independent investigation and appraisal
of the transactions contemplated hereby, and the Underwriters shall have no responsibility or liability to the Company with respect
thereto. Any review by the Underwriters of the Company, the transactions contemplated hereby or other matters relating to such
transactions will be performed solely for the benefit of the Underwriters and shall not be on behalf of the Company.

 

This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

This Agreement shall be governed by, and construed
in accordance with, the law of the State of New York, including, without limitation, Section 5-1401 of the New York General Obligations
Law.

 

    -27-

    

    

The Underwriters, on the one hand, and the
Company (on its own behalf and, to the extent permitted by law, on behalf of its stockholders), on the other hand, waive any right
to trial by jury in any action, claim, suit or proceeding with respect to your engagement as underwriter or your role in connection
herewith.

 

If the foregoing is in accordance with your
understanding of our agreement, please sign and return to us the enclosed duplicates hereof, whereupon it will become a binding
agreement among the Company and the several Underwriters in accordance with its terms.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    -28-

    

    

 

	 	Very truly yours,
	 	 
	 	TANZANIAN GOLD CORPORATION
	 	 
	 	 
	 	By:	/s/ James Sinclair
	 	 
	Name: James Sinclair

                    Title:Executive Chairman

 

 

 

 

 

 

 

 

 

    Signature Page Underwriting Agreement

    

    

 

The foregoing Underwriting Agreement

is hereby confirmed and accepted as

of the date first above written.

 

R.F. LAFFERTY & CO., INC.

 

As Representative of the several

Underwriters listed on Schedule I hereto

 

 

	By:	/s/ Robert
Hackel	 
	 
	Name: Robert
Hackel

                    Title:Chief
Operating Officer

 

 

 

 

 

 

    Signature Page Underwriting Agreement 

    

    

 

 

SCHEDULE I

 

Schedule
of Underwriters

 

	
        

Underwriter
	 
		 
	
        R.F. Lafferty & Co., Inc.

         
	 

 

 

 

 

 

 

 

 

 

 

 

    SCHEDULE I

    

    

 

SCHEDULE II

Issuer Free Writing Prospectus

 

None.

 

 

 

 

 

 

 

 

 

 

    SCHEDULE I

    

    

 

SCHEDULE 6(dd)

 

Amended NATIONAL INSTRUMENT 43-101, Independent
Technical Report Mineral Reserves Estimate and Pre-Feasibility Study on the Buckreef Gold Mine Project, Tanzania, East Africa
for Tanzanian Royalty Exploration Corporation (TRX), with an effective date of June 26, 2018.

 

 

 

 

 

 

 

 

SCHEDULE IEX-4.2

 Exhibit 4.2 

EXECUTION VERSION 

SUPPLEMENTAL INDENTURE NO. 17 

BY AND BETWEEN 

WELLTOWER INC. 
 AND

 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. 

AS OF DECEMBER 16, 2019 

SUPPLEMENTAL TO THE INDENTURE DATED AS OF MARCH 15, 2010 

WELLTOWER INC. 
 2.700%
NOTES DUE 2027 
  

 This SUPPLEMENTAL INDENTURE NO. 17 (this “Supplemental Indenture”) is made
and entered into as of December 16, 2019 between WELLTOWER INC., a Delaware corporation (the “Company”), and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., a national banking association duly organized and existing under the
laws of the United States of America, as Trustee (the “Trustee”). 
 WITNESSETH THAT: 

WHEREAS, the Company and the Trustee have executed and delivered an Indenture, dated as of March 15, 2010 (as amended, supplemented or
otherwise modified from time to time, the “Base Indenture” and, together with this Supplemental Indenture, as amended, supplemented or otherwise modified from time to time, the “Indenture”) to provide for the future
issuance of the Company’s senior debt securities (the “Securities”) to be issued from time to time in one or more series; and WHEREAS, pursuant to the terms of the Base Indenture, the Company desires to provide for the
establishment of a new series of its Securities, to be known as its 2.700% Notes due 2027, the form and substance of such Securities and the terms, provisions and conditions thereof to be set forth as provided in the Indenture. 

NOW, THEREFORE, THIS SUPPLEMENTAL INDENTURE WITNESSETH: 

ARTICLE 1 DEFINED TERMS 

Section 1.1 The following definitions supplement, and, to the extent inconsistent with, replace the definitions in Section 101 of
the Base Indenture: 
 “Board Resolution” means a copy of a resolution certified by the Secretary or an Assistant Secretary
of the Company to have been duly adopted by the Board and to be in full force and effect on the date of such certification, and delivered to the Trustee. 

“Business Day” means any day other than a Saturday or Sunday or a day on which banking institutions in the City of New York
are authorized or required by law, regulation or executive order to close. 
 “Cash” means as to any Person, such
Person’s cash and cash equivalents, as defined in accordance with GAAP consistently applied. 
 “Code” means the
Internal Revenue Code of 1986, as amended. 
 “DTC” means The Depository Trust Company located at 55 Water Street, 1SL, New
York, New York 10041-0099. 
 “EBITDA” means for any period, with respect to the Company and its subsidiaries on a
consolidated basis, determined in accordance with GAAP, the sum of net income (or net loss) for such period PLUS the sum of all amounts treated as expenses for: (i) interest, (ii) depreciation, (iii) amortization and (iv) all accrued
taxes on or measured by income to the extent included in the determination of such net income (or net loss); provided, however, that net income (or net loss) shall be computed without giving effect to extraordinary losses or gains. 

  
 1 

 “FATCA” means Sections 1471 through 1474 of the Code and related Treasury
regulations and pronouncements (the Foreign Account Tax Compliance Act). 
 “FATCA Withholding Tax” means any withholding
or deduction pursuant to an agreement described in Section 1471(b) of the Code or otherwise imposed pursuant to Sections 1471 through 1474 of the Code and any regulations, or agreements thereunder or official interpretations thereof or any
intergovernmental agreement between the United States and another jurisdiction facilitating the implementation thereof (or any law implementing such an intergovernmental agreement). 

“Funded Indebtedness” means as of any date of determination thereof, (i) all Indebtedness of any Person, determined in
accordance with GAAP, which by its terms matures more than one year after the date of calculation, and any such Indebtedness maturing within one year from such date which is renewable or extendable at the option of the obligor to a date more than
one year from such date, and (ii) the current portion of all such Indebtedness. 
 “GAAP” means generally accepted
accounting principles of the United States. 
 “Global Notes” has the meaning set forth in Section 2.1(a) of this
Supplemental Indenture. 
 “Indebtedness” means, with respect to any Person, all: (i) liabilities or obligations,
direct and contingent, which in accordance with GAAP would be included in determining total liabilities as shown on the liability side of a balance sheet of such Person at the date as of which Indebtedness is to be determined, including, without
limitation, contingent liabilities that in accordance with such principles, would be set forth in a specific dollar amount on the liability side of such balance sheet except to the extent any such liabilities or obligations include any operating
lease of property, real or personal; (ii) liabilities or obligations of others for which such Person is directly or indirectly liable, by way of guaranty (whether by direct guaranty, suretyship, discount, endorsement, take-or-pay agreement, agreement to purchase or advance or keep in funds or other agreement having the effect of a guaranty) or otherwise; (iii) liabilities or
obligations secured by Liens on any assets of such Person, whether or not such liabilities or obligations shall have been assumed by it; and (iv) liabilities or obligations of such Person, direct or contingent, with respect to letters of credit
issued for the account of such Person and bankers acceptances created for such Person. 
 “Interest Coverage” means as of
the last day of any fiscal quarter, the quotient, expressed as a percentage (which may be in excess of 100%), determined by dividing EBITDA by Interest Expense; all of the foregoing calculated by reference to the immediately preceding four fiscal
quarters ending on such date of determination. 
 “Interest Expense” means for any period, on a combined basis, the sum of
all interest paid or payable (excluding unamortized debt issuance costs) on all items of Indebtedness outstanding at any time during such period. 

“Interest Payment Date” with respect to the Notes is defined in Section 101 of the Base Indenture and
Section 2.1(b) of this Supplemental Indenture. 

  
 2 

 “Lien” means any mortgage, deed of trust, pledge, security interest,
encumbrance, lien, claim or charge of any kind (including any agreement to give any of the foregoing), any conditional sale or other title retention agreement, any lease in the nature of any of the foregoing, and the filing of or agreement to give
any financing statement under the Uniform Commercial Code of any jurisdiction. 
 “Make-Whole Amount” means, in connection
with any optional redemption of any Note, the excess, if any, of (i) the sum of the present values, as of the date of such redemption, of the remaining scheduled payments of principal of, and interest (exclusive of interest accrued to but
excluding the date of redemption) on, such Note, assuming such Note matured on, and that accrued and unpaid interest on such Note was payable through, the Par Call Date (as defined below), determined by discounting, on a semiannual basis (assuming a
360-day year consisting of twelve 30-day months), such principal and interest at the Reinvestment Rate (as defined below) (determined on the third Business Day preceding
the date of redemption) over (ii) the aggregate principal amount of the Note being redeemed. The Company will calculate such Make-Whole Amount. 

“Notes” means the Company’s 2.700% Notes due 2027, issued under the Indenture. 

“Officers’ Certificate” means a certificate signed by (i) the Chairman of the Board, a Vice Chairman of the Board,
the Chief Executive Officer, the Chief Operating Officer, the President or a Vice President, and (ii) the Chief Financial Officer, the Treasurer, an Assistant Treasurer, the Controller, the Secretary or an Assistant Secretary, of the Company,
and delivered to the Trustee. 
 “Par Call Date” means December 15, 2026. 

“Regular Record Date” with respect to the Notes is defined in Section 101 of the Base Indenture and Section 2.1(b)
of this Supplemental Indenture. 
 “Reinvestment Rate” means 0.150%, or 15 basis points, plus the arithmetic mean (rounded
to the nearest one-hundredth of one percent) of the yields displayed for each day in the preceding calendar week published in the most recent Statistical Release under the caption “Treasury constant
maturities” for the maturity (rounded to the nearest month) corresponding to the remaining life to maturity of the Notes (assuming that the Notes matured on the Par Call Date) as of the date of redemption. If no maturity exactly corresponds to
such remaining life to maturity, yields for the two published maturities most closely corresponding to such remaining life to maturity shall be calculated pursuant to the immediately preceding sentence and the Reinvestment Rate shall be interpolated
or extrapolated from such yields on a straight-line basis, rounding in each of such relevant periods to the nearest month. For the purpose of calculating the Reinvestment Rate, the most recent Statistical Release published prior to the date of
determination of the Reinvestment Rate shall be used. 
 “Senior Debt” means all Indebtedness other than Subordinated Debt.

 “Statistical Release” means that statistical release designated “H.15” or any successor publication that is
published daily by the Federal Reserve System and that establishes yields on actively traded United States Treasury securities adjusted to constant maturities, or, if such statistical release (or a successor publication) is not published at the time
of any determination under the Indenture, then such other reasonably comparable index that shall be designated by the Company. 

  
 3 

 “Subordinated Debt” means any unsecured Indebtedness of the Company which
is issued or assumed pursuant to, or evidenced by, an indenture or other instrument which contains provisions for the subordination of such other Indebtedness (to which appropriate reference shall be made in the instruments evidencing such other
Indebtedness if not contained therein) to the Notes (and, at the option of the Company, if so provided, to other Indebtedness of the Company, either generally or as specifically designated). 

“Subsidiary” means any corporation or other entity of which a majority of (i) the voting power of the voting equity
securities or (ii) the outstanding equity interests of which are owned, directly or indirectly, by the Company or one or more other Subsidiaries of the Company. For the purposes of this definition, “voting equity securities” means
equity securities having voting power for the election of directors or similar functionaries, whether at all times or only so long as no senior class of security has such voting power by reason of any contingency. 

“Total Assets” means on any date, the consolidated total assets of the Company and its Subsidiaries, as such amount would
appear on a consolidated balance sheet of the Company prepared as of such date in accordance with GAAP. 
 “Total Unencumbered
Assets” means on any date, net real estate investments (valued on a book basis) of the Company and its Subsidiaries that are not subject to any Lien which secures indebtedness for borrowed money of any of the Company and its Subsidiaries
plus, without duplication, loan loss reserves relating thereto, accumulated depreciation thereon plus Cash, as all such amounts would appear on a consolidated balance sheet of the Company prepared as of such date in accordance with GAAP; provided,
however, that “Total Unencumbered Assets” does not include net real estate investments under unconsolidated joint ventures of the Company and its Subsidiaries. 

“Unsecured Debt” means Funded Indebtedness less Indebtedness secured by Liens on the property or assets of the Company and
its Subsidiaries. 
 ARTICLE 2 

TERMS OF THE NOTES 

Section 2.1 Pursuant to Section 301 of the Indenture, the Notes shall have the following terms and conditions: 

(a) Title; Aggregate Principal Amount; Form of Notes. The Notes shall be Registered Securities under the Indenture and shall be known as
the Company’s “2.700% Notes due 2027.” The Notes will be limited to an aggregate principal amount of $500,000,000, subject to the right of the Company to reopen such series for issuances of additional securities of such series and
except (i) as provided in this Section 2.1(a) and (ii) for Securities authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities of the

  
 4 

 
series pursuant to Section 304, 305, 306, 906 or 1107 of the Indenture and except for any Securities which, pursuant to Section 303 of the Indenture, are deemed never to have been
authenticated and delivered hereunder. The Notes (together with the Trustee’s certificate of authentication) shall be substantially in the form of Exhibit A hereto, which is hereby incorporated in and made a part of this Supplemental
Indenture. 
 The Notes will be issued in the form of fully registered global securities without coupons (“Global Notes”) that
will be deposited with, or on behalf of, DTC, and registered in the name of DTC’s partnership nominee, Cede & Co. Except under the circumstance described below, the Notes will not be issuable in definitive form. Unless and until it is
exchanged in whole or in part for the individual Notes represented thereby, a Global Note may not be transferred except as a whole by DTC to a nominee of DTC or by a nominee of DTC to DTC or another nominee of DTC or by DTC or any nominee of DTC to
a successor depositary or any nominee of such successor. 
 So long as DTC or its nominee is the registered owner of a Global Note, DTC or
such nominee, as the case may be, will be considered the sole owner or Holder of the Notes represented by such Global Note for all purposes under this Supplemental Indenture. Except as described below, owners of beneficial interest in Notes
evidenced by a Global Note will not be entitled to have any of the individual Notes represented by such Global Note registered in their names, will not receive or be entitled to receive physical delivery of any such Notes in definitive form and will
not be considered the owners or Holders thereof under the Indenture or this Supplemental Indenture. 
 If DTC is at any time unwilling,
unable or ineligible to continue as depositary and a successor depositary is not appointed by the Company within 90 days, the Company will issue individual Notes in exchange for the Global Note or Global Notes representing such Notes. In addition,
the Company may at any time and in its sole discretion, subject to certain limitations set forth in the Indenture, determine not to have any of such Notes represented by one or more Global Notes and, in such event, will issue individual Notes in
exchange for the Global Note or Global Notes representing the Notes. Individual Notes so issued will be issued in minimum denominations of $2,000 and integral multiples of $1,000. 

(b) Interest and Interest Rate. The Notes will bear interest at a rate of 2.700% per annum, from December 16, 2019 (or, in the case
of Notes issued upon the reopening of this series of Notes, from the date designated by the Company in connection with such reopening) or from the immediately preceding Interest Payment Date to which interest has been paid or duly provided for,
payable semi-annually in arrears on each of February 15 and August 15, commencing August 15, 2020 (each of which shall be an “Interest Payment Date”), to the Persons in whose names the Notes are registered in the
Security Register at the close of business on February 1 or August 1, as the case may be (whether or not a Business Day), next preceding such Interest Payment Date (each, a “Regular Record Date”). 

(c) Principal Repayment; Currency. The Notes will mature on February 15, 2027, provided, however, the Notes may be earlier redeemed
at the option of the Company as provided in paragraph (d) below. The principal of each Note payable on its maturity date or date of earlier redemption shall be paid against presentation and surrender thereof to the Corporate Trust Operations of
the Trustee, located at 111 Sanders Creek Parkway, East Syracuse, NY 13057, in such coin or currency of the United States of America as at the time of payment is legal tender for the payment of public or private debts. 

  
 5 

 (d) Redemption at the Option of the Company. The Notes will be subject to redemption
at the option of the Company, at any time in whole or from time to time in part, upon not less than 15 nor more than 30 days’ notice transmitted to each Holder of Notes to be redeemed as shown in the Security Register. If the Notes are
redeemed, the redemption price will equal to the sum of (i) 100% of the principal amount of the Notes (or portion of such Notes) being redeemed plus accrued and unpaid interest thereon to but excluding the redemption date and (ii) the
Make-Whole Amount, if any; provided, however, that if the Notes are redeemed on or after the Par Call Date, the redemption price will equal 100% of the principal amount of the Notes (or portion of such Notes) being redeemed plus accrued and unpaid
interest thereon to but excluding the redemption date. Notwithstanding the foregoing, the Company will pay any interest installment due on an Interest Payment Date which occurs on or prior to a redemption date to the Holders of the Notes as of the
close of business on the Regular Record Date immediately preceding such Interest Payment Date. The Company shall calculate the redemption price. The election to redeem the Notes may be evidenced by either a Board Resolution or an Officers’
Certificate. 
 (e) Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly
given if mailed or transmitted by facsimile. Notices to the Company shall be directed to it at 4500 Dorr Street, Toledo, Ohio 43615, Attention: General Counsel; notices to the Trustee shall be directed to it at The Bank of New York Mellon Trust
Company, N.A., 2 North LaSalle Street, Suite 700, Chicago, Illinois 60602, Attention: Corporate Trust Administration, Re: Welltower Inc. 2.700% Notes due 2027; or as to either party, at such other address as shall be designated by such party in a
written notice to the other party. In addition to the foregoing, the Trustee agrees to accept and act upon instructions or directions pursuant to the Indenture sent by unsecured e-mail, pdf, facsimile
transmission or other similar unsecured electronic methods, provided, however, that the Trustee shall have received an incumbency certificate listing persons designated to give such instructions or directions and containing specimen signatures of
such designated persons, which such incumbency certificate shall be amended and replaced whenever a person is to be added or deleted from the listing. If the Company elects to give the Trustee e-mail or
facsimile instructions (or instructions by a similar electronic method) and the Trustee in its discretion elects to act upon such instructions, the Trustee’s understanding of such instructions shall be deemed controlling. The Trustee shall not
be liable for any losses, costs or expenses arising directly or indirectly from the Trustee’s reliance upon and compliance with such instructions notwithstanding such instructions’ conflict or are inconsistent with a subsequent written
instruction. The Company agrees to assume all risks arising out of the use of such electronic methods to submit instructions and directions to the Trustee, including without limitation the risk of the Trustee acting on unauthorized instructions, and
the risk or interception and misuse by third parties. 

  
 6 

 (f) Global Note Legend. Each Global Note shall bear the following legend on the face
thereof: 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION
(“DTC”), TO ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC
(AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE
REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 
 (g) Applicability of Discharge, Defeasance and Covenant
Defeasance Provisions. The Discharge, Defeasance and Covenant Defeasance provisions in Article Thirteen of the Indenture will apply to the Notes. 

ARTICLE 3 
 ADDITIONAL
COVENANTS 
 Section 3.1 Holders of the Notes shall have the benefit of the following covenants, in addition to the covenants of
the Company set forth in Articles Eight and Ten of the Indenture: 
 (a) The Company will not pledge or otherwise subject to any Lien, any
property or assets of the Company or its Subsidiaries unless the Notes are secured by such pledge or Lien equally and ratably with all other obligations secured thereby so long as such other obligations shall be so secured; provided, however, that
such covenant shall not apply to the following: 
 (i) Liens securing obligations that do not in the aggregate at any one
time outstanding exceed 40% of the sum of (A) the Total Assets of the Company and its consolidated subsidiaries as of the end of the calendar year or quarter covered in the Company’s Annual Report on Form
10-K or Quarterly Report on Form 10-Q, as the case may be, most recently filed with the Commission (or, if such filing is not permitted under the Exchange Act, with the
Trustee) prior to the incurrence of such additional Liens and (B) the purchase price of any real estate assets or mortgages receivable acquired, and the amount of any securities offering proceeds received (to the extent that such proceeds were
not used to acquire real estate assets or mortgages receivable or used to reduce Indebtedness), by the Company or any Subsidiary since the end of such calendar quarter, including those proceeds obtained in connection with the incurrence of such
additional Liens; 
 (ii) Pledges or deposits by the Company or its Subsidiaries under workers’ compensation laws,
unemployment insurance laws, social security laws, or similar legislation, or good faith deposits in connection with bids, tenders, contracts (other than for the payment of Indebtedness of the Company or its Subsidiaries), or leases to which the
Company or any of its Subsidiaries is a party, or deposits to secure public or statutory obligations of the Company or its Subsidiaries or deposits of cash or United States Government Bonds to secure surety, appeal, performance or other similar
bonds to which the Company or any of its Subsidiaries is a party, or deposits as security for contested taxes or import duties or for the payment of rent; 

  
 7 

 (iii) Liens imposed by law, such as carriers’, warehousemen’s,
materialmen’s and mechanics’ liens, or Liens arising out of judgments or awards against the Company or any of its Subsidiaries which the Company or such Subsidiary at the time shall be currently prosecuting an appeal or proceeding for
review; 
 (iv) Liens for taxes not yet subject to penalties for non-payment and
Liens for taxes the payment of which is being contested in good faith and by appropriate proceedings; 
 (v) Minor survey
exceptions, minor encumbrances, easements or reservations of, or rights of, others for rights of way, highways and railroad crossings, sewers, electric lines, telegraph and telephone lines and other similar purposes, or zoning or other restrictions
as to the use of real properties; 
 (vi) Liens incidental to the conduct of the business of the Company or any Subsidiary or
to the ownership of their respective properties that were not incurred in connection with Indebtedness of the Company or such Subsidiary, all of which Liens referred to in this clause (vi) do not in the aggregate materially impair the value of
the properties to which they relate or materially impair their use in the operation of the business taken as a whole of the Company and its Subsidiaries, and as to all of the foregoing referenced in clauses (ii) through (vi), only to the extent
arising and continuing in the ordinary course of business; 
 (vii) Purchase money Liens on property acquired or held by the
Company or its Subsidiaries in the ordinary course of business, securing Indebtedness incurred or assumed for the purpose of financing all or any part of the cost of such property; provided, however, that (A) any such Lien attaches concurrently
with or within 20 days after the acquisition thereof, (B) such Lien attaches solely to the property so acquired in such transaction, (C) the principal amount of the Indebtedness secured thereby does not exceed 100% of the cost of such
property and (D) the aggregate amount of all such Indebtedness on a consolidated basis for the Company and its Subsidiaries shall not at any time exceed $1,000,000; 

(viii) Liens existing on the Company’s balance sheet as of December 31, 2001; and 

(ix) Any extension, renewal or replacement (or successive extensions, renewals or replacements), as a whole or in part, of any
Lien referred to in the foregoing clauses (ii) through (viii) inclusive; provided, however, that the amount of any and all obligations and Indebtedness secured thereby shall not exceed the amount thereof so secured immediately prior to the time
of such extension, renewal or replacement and that such extension, renewal or replacement shall be limited to all or a part of the property which secured the Lien so extended, renewed or replaced (plus improvements on such property). 

  
 8 

 (b) The Company will not create, assume, incur, or otherwise become liable in respect of,
any Indebtedness if the aggregate outstanding principal amount of Indebtedness of the Company and its consolidated subsidiaries is, at the time of such creation, assumption or incurrence and after giving effect thereto and to any concurrent
transactions, greater than 60% of the sum of (i) the Total Assets of the Company and its consolidated subsidiaries as of the end of the calendar year or quarter covered in the Company’s Annual Report on Form
10-K or Quarterly Report on Form 10-Q, as the case may be, most recently filed with the Commission (or, if such filing is not permitted under the Exchange Act, with the
Trustee) prior to the incurrence of such additional Indebtedness and (ii) the purchase price of any real estate assets or mortgages receivable acquired, and the amount of any securities offering proceeds received (to the extent that such
proceeds were not used to acquire real estate assets or mortgages receivable or used to reduce Indebtedness), by the Company or any Subsidiary since the end of such calendar quarter, including those proceeds obtained in connection with the
incurrence of such additional Indebtedness. 
 (c) The Company will have or maintain, on a consolidated basis, as of the last day of each of
the Company’s fiscal quarters, Interest Coverage of not less than 150%. 
 (d) The Company will maintain, at all times, Total
Unencumbered Assets of not less than 150% of the aggregate outstanding principal amount of the Unsecured Debt of the Company and its Subsidiaries on a consolidated basis. 

(e) For purposes of this Section 3.1, Indebtedness and Debt shall be deemed to be “incurred” by the Company or a Subsidiary
whenever the Company or such Subsidiary shall create, assume, guarantee or otherwise become liable in respect thereof. 
 ARTICLE 4

 ADDITIONAL EVENTS OF DEFAULT 

Section 4.1 For purposes of this Supplemental Indenture and the Notes, in addition to the Events of Default set forth in Section 501
of the Indenture, each of the following also shall constitute an “Event of Default:” 
 (a) default in the payment of the
principal of or any premium on the Notes at Maturity; 
 (b) there shall occur a default under any bond, debenture, note or other evidence of
indebtedness of the Company, or under any mortgage, indenture or other instrument of the Company (including a default with respect to Securities of any series other than that series) under which there may be issued or by which there may be secured
any indebtedness of the Company (or by any Subsidiary, the repayment of which the Company has guaranteed or for which the Company is directly responsible or liable as obligor or guarantor), whether such indebtedness now exists or shall hereafter be
created, which default shall relate to an aggregate principal amount exceeding $10,000,000 of such indebtedness when due and payable after the expiration of any 

  
 9 

 
applicable grace period with respect thereto and shall have resulted in such indebtedness in an aggregate principal amount exceeding $10,000,000 becoming or being declared due and payable prior
to the date on which it would otherwise have become due and payable, without such indebtedness having been discharged, or such acceleration having been rescinded or annulled, within a period of 10 days after there shall have been given, by first
class mail or electronically, as applicable, to the Company by the Trustee or to the Company and the Trustee by the Holders of more than 50% in principal amount of the Outstanding Notes a written notice specifying such default and requiring the
Company to cause such indebtedness to be discharged or cause such acceleration to be rescinded or annulled and stating that such notice is a “Notice of Default” under the Indenture; and 

(c) the entry by a court of competent jurisdiction of one or more judgments, orders or decrees against the Company or any of its Subsidiaries
in an aggregate amount (excluding amounts fully covered by insurance) in excess of $10,000,000 and such judgments, orders or decrees remain undischarged, unstayed and unsatisfied in an aggregate amount (excluding amounts fully covered by insurance)
in excess of $10,000,000 for a period of 30 consecutive days. 
 Section 4.2 Notwithstanding any provisions to the contrary in the
Indenture, upon the acceleration of the Notes in accordance with Section 502 of the Indenture, the amount immediately due and payable in respect of the Notes shall equal the Outstanding principal amount thereof, plus accrued and unpaid
interest, plus the Make-Whole Amount. 
 ARTICLE 5 

EFFECTIVENESS 

Section 5.1 This Supplemental Indenture shall be effective for all purposes as of the date and time this Supplemental Indenture has been
executed and delivered by the Company and the Trustee in accordance with Article Nine of the Indenture. As supplemented hereby, the Indenture is hereby confirmed as being in full force and effect. 

ARTICLE 6 
 NOTICE TO
TRUSTEE 
 Section 6.1 Notwithstanding anything to the contrary in the Indenture including, without limitation, Section 1102
thereof, in connection with the redemption at the election of the Company of less than all the Notes, the Company shall notify the Trustee of the establishment of a redemption date and the principal amount of Notes to be redeemed at least five
Business Days prior to such redemption date unless a shorter period shall be satisfactory to the Trustee. 

  
 10 

 ARTICLE 7 

MISCELLANEOUS 

Section 7.1 In the event any provision of this Supplemental Indenture shall be held invalid or unenforceable by any court of competent
jurisdiction, such holding shall not invalidate or render unenforceable any other provision hereof or any provision of the Indenture. 

Section 7.2 To the extent that any terms of this Supplemental Indenture or the Notes are inconsistent with the terms of the Indenture,
the terms of this Supplemental Indenture or the Notes shall govern and supersede such inconsistent terms. 
 Section 7.3 This
Supplemental Indenture shall be governed by and construed in accordance with the laws of the State of New York. 
 Section 7.4 This
Supplemental Indenture may be executed in several counterparts, each of which shall be an original and all of which shall constitute but one and the same instrument. 

Section 7.5 The Trustee shall not be responsible for the validity or sufficiency of this Supplemental Indenture, or for the recitals
contained herein, all of which shall be taken as statements of the Company. 
 Section 7.6 In order to comply with applicable tax laws,
rules and regulations (inclusive of directives, guidelines and interpretations promulgated by competent authorities) in effect from time to time (“Applicable Law”), the Company agrees (a) to provide to the Trustee sufficient
information about Holders or other applicable parties and/or transactions (including any modification to the terms of such transactions) so the Trustee can determine whether it has tax-related obligations
under Applicable Law, (b) that the Trustee shall be entitled to make any withholding or deduction from payments under the Indenture to the extent necessary to comply with Applicable Law for which the Trustee shall not have any liability, and
(c) to hold harmless the Trustee for any losses it may suffer due to the actions it takes to comply with such Applicable Law. The terms of this Section 7.6 shall survive the termination of the Indenture. 

Section 7.7 The Trustee shall be entitled to deduct FATCA Withholding Tax, and shall have no obligation to
gross-up any payment hereunder or to pay any additional amount as a result of such FATCA Withholding Tax. 

  
 11 

 IN WITNESS WHEREOF, the Company and the Trustee have caused this Supplemental Indenture to
be executed in their respective corporate names as of the date first above written. 
  

			
	WELLTOWER INC.
		
	By:	 	 /s/ Matthew McQueen

	Name:	 	Matthew McQueen
	Title:	 	Senior Vice President – General Counsel & Corporate Secretary

  

  
 [Signature Page to
Supplemental Indenture No. 17] 

 
			
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee
		
	By:	 	 /s/ Lawrence M. Kusch

	Name:	 	Lawrence M. Kusch
	Title:	 	Vice President

  
 [Signature Page to
Supplemental Indenture No. 17] 

 EXHIBIT A 

FORM OF NOTE 

 WELLTOWER INC. 

UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK
CORPORATION (“DTC”), TO ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED
REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL
INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 
 2.700% Note due 2027 

 

			
	No. A-[     ]	  	
		
	CUSIP No. 95040Q AK0	  	$[         ]

 Welltower Inc., a corporation duly organized and existing under the laws of the State of Delaware (herein
called the “Company,” which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to Cede & Co., or registered assigns, the principal sum of
[                ] on February 15, 2027, and to pay interest thereon from December 16, 2019, or from the most recent Interest Payment Date to which interest
has been paid or duly provided for, semi-annually in arrears on February 15 and August 15 in each year, commencing August 15, 2020 at the rate of 2.700% per annum, until the principal hereof is paid or made available for payment. The
interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of
business on the Regular Record Date for such interest, which shall be on February 1 or August 1 (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date. Any such interest not so punctually paid or
duly provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a
Special Record Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such Special Record Date, or be paid at any time in any
other lawful manner not inconsistent with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture. This
Security is entitled to the benefits of the Indenture. 

 Payment of the principal of (and premium, if any) and any such interest on this Security
will be made at the office or agency of the Company maintained for that purpose in the City of New York, New York, or elsewhere as provided in the Indenture, in such coin or currency of the United States of America as at the time of payment is legal
tender for payment of public and private debts; provided, however, that at the option of the Company payment of interest may be made by electronic wire transfer or by check mailed to the address of the Person entitled thereto as such address shall
appear in the Security Register. 
 Reference is hereby made to the further provisions of this Security set forth on the reverse hereof,
which further provisions shall for all purposes have the same effect as if set forth at this place. 
 No recourse under or upon any
obligation, covenant or agreement contained in the Indenture or in this Security, or because of any indebtedness evidenced hereby or thereby, shall be had against any promoter, as such, or against any past, present or future shareholder, officer or
director, as such, of the Company or of any successor, either directly or through the Company or any successor, under any rule of law, statute or constitutional provision or by the enforcement of any assessment or by any legal or equitable
proceeding or otherwise, all such liability being expressly waived and released by the acceptance of this Security by the Holder thereof and as part of the consideration for the issue of the Securities of this series. 

Unless the certificate of authentication hereon has been executed by the Trustee referred to on the reverse hereof by manual signature, this
Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 
 [Signature page follows] 

 In Witness Whereof, the Company has caused this instrument to be duly executed under its
corporate seal. 
  

			
	WELLTOWER INC.

 
			
		
	By:	 	  

 
			
	Name:	 	
	Title:	 	

 CERTIFICATE OF AUTHENTICATION 

Dated:
                                         
    
 This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. 

 

			
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N. A., as Trustee

 
			
		
	By:	 	  

		 	        Authorized Signatory

 [Form of Reverse of Security] 

1. General. This Security is one of a duly authorized issue of securities of the Company (herein called the
“Securities”), issued and to be issued in one or more series under an Indenture, dated as of March 15, 2010 (as amended, supplemented or otherwise modified from time to time, the “Base Indenture”), as
supplemented by Supplemental Indenture No. 17, dated as of December 16, 2019 (as amended, supplemented or otherwise modified from time to time, the “Supplemental Indenture” and the Base Indenture, as supplemented by such
Supplemental Indenture, the “Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (herein called the “Trustee,” which term includes any successor trustee under the
Indenture), and reference is hereby made to the Indenture for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee, the holders of Senior Debt and the Holders of the Securities and
of the terms upon which the Securities are, and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof. 

2. Optional Redemption. The Securities of this series are subject to redemption, at any time or from time to time, as a whole or in
part, at the election of the Company. If the Securities of this series are redeemed, the redemption price will equal to the sum of (i) 100% of the principal amount of the Securities (or portion of such Securities) being redeemed plus accrued and
unpaid interest thereon to but excluding the redemption date and (ii) the Make-Whole Amount, if any; provided, however, that if the Securities are redeemed on or after the Par Call Date, the redemption price will equal 100% of the principal
amount of the Securities (or portion of such Securities) being redeemed plus accrued and unpaid interest thereon to but excluding the redemption date. Notwithstanding the foregoing, the Company will pay any interest installment due on an Interest
Payment Date which occurs on or prior to a redemption date to the Holders of the Notes as of the close of business on the Notes Regular Record Date immediately preceding such Interest Payment Date. The Company shall calculate the redemption price.
The election to redeem the Securities may be evidenced by either a Board Resolution or an Officers’ Certificate. 
 In the event of
redemption of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed portion hereof will be issued in the name of the Holder hereof upon the cancellation hereof. 

3. Defeasance. The Indenture contains provisions for defeasance at any time of the entire indebtedness of this Security or certain
restrictive covenants and Events of Default with respect to this Security, in each case upon compliance with certain conditions set forth in the Indenture. 

4. Defaults and Remedies. If an Event of Default with respect to Securities of this series shall occur and be continuing, the principal
of the Securities of this series may be declared due and payable in the manner and with the effect provided in the Indenture. 

 5. Actions of Holders. The Indenture permits, with certain exceptions as therein
provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the
consent of the Holders of not less than a majority in principal amount of the Securities at the time Outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal
amount of the Securities of each series at the time Outstanding, on behalf of the Holders of all Securities of such series, to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and
their consequences. Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the registration of transfer hereof or in
exchange therefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Security. 
 As provided in and
subject to the provisions of the Indenture, the Holder of this Security shall not have the right to institute any proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless
such Holder shall have previously given the Trustee written notice of a continuing Event of Default with respect to the Securities of this series, the Holders of not less than a majority in principal amount of the Securities of this series at the
time Outstanding shall have made written request to the Trustee to institute proceedings in respect of such Event of Default as Trustee and offered the Trustee reasonable indemnity, and the Trustee shall not have received from the Holders of a
majority in principal amount of Securities of this series at the time Outstanding a direction inconsistent with such request, and shall have failed to institute any such proceeding, for 60 days after receipt of such notice, request and offer of
indemnity. The foregoing shall not apply to any suit instituted by the Holder of this Security for the enforcement of any payment of principal hereof or any premium or interest hereon on or after the respective due dates expressed herein. 

6. Payments Not Impaired. No reference herein to the Indenture and no provision of this Security or of the Indenture shall alter or
impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security at the times, place and rate, and in the coin or currency, herein prescribed. 

7. Denominations, Transfer, Exchange. As provided in the Indenture and subject to certain limitations therein set forth, the transfer of
this Security is registrable in the Security Register, upon surrender of this Security for registration of transfer at the office or agency of the Company in any place where the principal of and any premium and interest on this Security are payable,
duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new
Securities of this series and of like tenor, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. 

The Securities of this series are issuable only in registered form without coupons in minimum denominations of $2,000 and any integral
multiple of $1,000. As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series and of like tenor of a different
authorized denomination, as requested by the Holder surrendering the same. 

 No service charge shall be made for any such registration of transfer or exchange, but the
Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 
 8.
Persons Deemed Owners. Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name this Security is registered as the owner
hereof for all purposes, whether or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. 

9. Defined Terms. All terms used in this Security which are defined in the Indenture shall have the meanings assigned to them in the
Indenture. 
 10. Governing Law. The Indenture and this Security shall be deemed to be a contract made under the laws of the State of
New York, and for all purposes shall be construed in accordance with the laws of said state. 
 11. CUSIP Number. Pursuant to a
recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP numbers to be printed on the Securities as a convenience to the Holders of the Securities. No representation is made as to the
correctness or accuracy of such CUSIP numbers as printed on the Securities, and reliance may be placed only on the other identification numbers printed hereon. 

 [ASSIGNMENT FORM] 

ABBREVIATIONS 
 The
following abbreviations, when used in the inscription on the face of this instrument, shall be construed as though they were written out in full according to applicable laws or regulations: 

 

							
	TEN COM — as tenants in common	  	        	  	UNIF GIFT MIN ACT	 	–              Custodian             
	TEN ENT — as tenants by the entireties	  		  		 	    (Cost)                     (Minor)
	 JT TEN — as joint tenants with right of survivorship and

                   not as tenants in common
	  		 	     Under Uniform Gifts to Minors Act
		  		  		 	                        
		  		  		 	(State)

 Additional abbreviations may also be used though not in the above list. 

                         
        
 FOR VALUE RECEIVED, the undersigned registered holder hereby sell(s), assign(s) and transfer(s) unto

  
  

PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE 
  

 
 PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS OF
ASSIGNEE 
 the within security and all rights thereunder, hereby irrevocably constituting and appointing _______________________________ Attorney to
transfer said security on the books of the Company with full power of substitution in the premises. 
  

							
	Dated:
                                         
                       	 		 		 	Signed:
                                         
                               
				
		 		 		 	Notice: The signature to this assignment must correspond with the name as it appears upon the face of the within security in every particular, without alteration or enlargement or any change whatever.
				
		 		 		 	Signature Guarantee*:
                                    
				
		 		 		 	* Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee).

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}]]